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MEASUREMENT OF RED BLOOD CELL OXYGENATION STATE BY
MAGNETOPHORESIS
NINA A. SMITH
ABSTRACT
Magnetophoresis of red blood cells (RBCs) at varying partial pressures of oxygen
(pO2) is hypothesized to rejuvenate stored blood to be utilized beyond the FDA regulated
42-day storage time. Magnetophoresis is a particle or cells motion induced by an applied
magnetic field in a viscous media. The average magnetophoretic mobility of an oxygenated
RBC is -0.126x10-6 mm3-s/kg, and a deoxygenated RBC is 3.66x10-6 mm3-s/kg, presenting
magnetophoresis as a resource for RBC rejuvenation in hopes of storing it longer than 42
days. The main objective of this paper was to determine if controlling the pO2 within an
RBC suspension, can singly- doubly- triply- or fully deoxygenated RBCs be identified by
means of cell tracking velocimetry (CTV). These results agreed with the cooperative
binding scheme developed by Hill, especially from ~30-40 to 160 mmHg. From 0 to 30
mmHg, further research must be completed to characterize the binding behavior of oxygen
and hemoglobin. The validation of the magnetic energy density gradient value (Sm,
currently at 365 T-A/mm2) utilized within CTV, and the exact location for the field of view
(FOV, currently set to 4.5 mm from the edge of the magnet assembly) were needed to state
particle motion was independent of location within the CTV channel. The FOV location
was successfully verified 4.5 mm from the edge of the magnet assembly, however, the Sm
value, 880 T-A/mm2, was 140% higher than the original. Spectrophotometry was utilized
to validate the oxygenation state of RBCs. Results confirmed spectrophotometry was a
reliable model for RBC magnetophoresis. CTV post-processing was tested with glioma

vi

progenitor cells. Scatter plots generated for these experiments demonstrated cells with
different magnetic mobilities in a sample can be detected. To fully characterize the glioma
progenitor cells, more experiments must be completed. Lastly, applying a temperature
gradient to the magnetic deposition microscopy (MDM) assembly to enhance the
separation of RBCs was explored. Preliminary results determined, introducing a
temperature gradient of 40°C was large enough to affect the RBC sedimentation rate in the
channel. After, modeling within COMSOL was completed, however, more time and
knowledge of COMSOL is needed to generate practical results.
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CHAPTER I
INTRODUCTION
1.1 Introduction
Red blood cell (RBC) transfusions are needed by patients for a variety of reasons,
such as to replace blood loss during a surgical procedure or trauma, or an illness which
may cause anemia like liver disease, a hematological disease, or cancer (Why patients
receive blood transfusions, 2019). A unit of RBCs is only able to be preserved and stored
in a refrigerator for 42 days (Sparrow, 2010). The preservation solution most commonly
utilized is saline-adenine-glucose-mannitol (SAG-M), which also extends the shelf-life of
the RBCs (Sparrow, 2010). While stored, RBCs undergo physicochemical changes, which
decreases the quality, function, and in vivo survival, due to being out of their natural
environment (Sparrow, 2010). Depending on the storage duration of an RBC unit, there is
a possibility that up to 25% of transfused RBCs clear from a recipient's circulation within
24 hours (Moore, et al., 2018). As the need for a technique to separate fresh RBCs from
aged RBCs arises, a possible solution is magnetic separation.
As of 2002, magnetic separation has grown in the life sciences, particularly for cell
separation (Zborowski, et al., 1995). As an RBC ages, it loses its ability to release oxygen
(Haidas, et al., 1971), which in turn causes its magnetic properties to change (Pauling &
1

Coryell, 1936b), and it becomes more diamagnetic relative to water (Jin, et al., 2012). This
will be described further in Section 2.1. This results in a difference in the magnetophoresis
of aged RBCs compared to fresh RBCs, where magnetophoresis is defined as the particle
motion created by an applied magnetic field within a viscous media (Zborowski, et al.,
2016). This magnetophoretic difference allows magnetic separation to be a feasible
technique for isolating oxygen functional RBCs in stored blood from non-oxygen
functional RBCs, to be utilized for transfusions.
1.2 Hypothesis
Based on previous studies, it is known that the magnetic susceptibility of RBCs
changes at two oxygen partial pressure (pO2) extrema values of ~0 mmHg (high
susceptibility) and ~160 mmHg (in ambient air, low susceptibility). Magnetic susceptibility
of a material is defined as the response the material has to an applied magnetic field.
However, the dependence of the RBC susceptibility on pO2 values between these two
extremes was never studied. It is also known that the chemical kinetics of the oxygen
binding to hemoglobin follows a cooperative binding model characterized by the Adair and
Hill equations. With this information, it was hypothesized that the magnetic susceptibility
of RBCs follows the same cooperative binding dependence on pO2. This hypothesis was
made because it is known that the magnetic susceptibility of hemoglobin decreases linearly
when the number of bound oxygen (O2) molecules to hemoglobin increases. In other words,
we expect that RBC magnetophoresis depends on the oxygenation state of intracellular
hemoglobin in a manner that is well understood theoretically, but has never been examined
in detail experimentally. Therefore, under carefully controlled oxygenation conditions, the
hypothesis was tested to determine if cell tracking velocimetry (CTV) is capable of
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differentiating RBC subfractions differing in oxygenation state with sufficient accuracy. In
turn, this would also determine if the dependence of RBC susceptibility on pO2 follows the
cooperative binding model of Adair and Hill.
1.3 Specific Aims
To prove this hypothesis, a variety of experiments were performed.
1. To determine the optimal magnetophoretic driving force vector, Sm, and the optimal
field of view (FOV) location for cell tracking velocimetry (CTV) applications to
study the magnetophoresis of red blood cells (RBCs). The optimal location of the
FOV is where the Sm magnitude and the magnetic field-induced particle velocity
does not depend on position inside the FOV. This will ensure the most accurate
measurement of RBC velocities during deoxygenation experiments. These
experiments were completed utilizing polystyrene (PS) particles within a 50/50
mixture of Magnevist, which is a chelated and stabilized form of gadolinium, and
a special buffer formulation with a defined magnetic susceptibility.
2. To measure the absorbance of a blood sample to determine the methemoglobin
(metHb) and oxyhemoglobin (oxyHb) concentration levels within it through
spectrophotometry as a means to validate RBC deoxygenation. This technique was
used to measure intraerythrocytic metHb concentration as the surrogate of
deoxygenated RBCs. The data were analyzed with the equations stated in
Winterbourne’s paper (Winterbourn, 1990) to determine the oxyHb, metHb, and
hemichrome concentration levels within a metHb and oxyHb sample.
3. To modify the CTV system to facilitate the deoxygenation of RBCs for
magnetophoresis experiments. The system modifications allowed for precisely
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controlled deoxygenation of RBCs while their magnetophoretic motion was
analyzed by CTV.
4. To measure the magnetophoretic mobility of RBCs at varying oxygenation levels,
to study the effect of O2 binding to hemoglobin (Hb-O2) on red blood cell
magnetization. The Hb-O2 reaction kinetics is known from Hb-O2 equilibrium
curves determined spectrophotometrically, however, spectrophotometry of the bulk
sample does not provide details about the cooperative binding process. The purpose
of this study was to determine if RBC magnetophoresis as a function of Hb-O2
binding could provide details about individual stages of a cooperative binding.
5. To validate CTV data post-processing capabilities using the model of glioma
progenitor cells known for atypical iron metabolism and to compare their magnetic
velocities with the magnetic velocities of oxygenated and deoxygenated RBCs.
These experiments were used to validate the sensitivity of CTV to distinguish
differences in magnetic velocities of different cell types other than RBCs, such as
3T3, GL26, and GL261 cell lines. The CTV data was analyzed by a newly
developed MATLAB code.
6. To model and explore the effects of convective transport with a temperature
gradient as a possible option to enhance RBC magnetic separation. This would
determine if convective transport heightened by a temperature gradient is a feasible
approach to high throughput RBC separation. Modeling within COMSOL was
briefly explored to determine if cooling the MDM magnet to 0°C and heating the
opposite wall to 40 or 60°C would allow for faster and higher recovery of fresh
(magnetic) RBCs.

4

1.4 Significance of Research
The significance of this research is in its contribution to understanding the physical
processes associated with stored blood aging, with potential applications to stored blood
“rejuvenation,” so that blood could be safely used beyond the current limit of 42 days.
Specifically, this study investigates how the oxygen concentration in solution influences
the magnetic field-induced velocity of an RBC in suspension. The accumulation of oxygen
binding defects in RBCs over the blood storage time contributes to the current limit of 42
days. Such defects have been shown within Dr. Maciej Zborowski’s laboratory at the
Cleveland Clinic, the site of this research, and by collaborators, to affect the magnetically
induced RBC velocity, which therefore could provide a basis for selective depletion of the
non-functional RBCs. This research contributes to the future design of a magnetic RBC
sorter that could improve the quality of stored blood and therefore extend the storage time
for banked blood.
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CHAPTER II
BACKGROUND
2.1 Red Blood Cell Properties
A general understanding of the biology of an RBC is needed before proceeding
with the experiments described in Chapter I. About 270 million hemoglobin molecules are
present within a mature RBC, accounting for approximately 90% of an RBC’s dry weight
(D'Alessandro, et al., 2017). For every hemoglobin molecule there are four folded globin
proteins, two beta chains and two alpha chains, each containing its own heme group, which
is a red pigmented molecule with the capabilities of binding to an iron ion (Fe2+, ferrous)
(Erythrocytes, 2013). Figure 1 represents what a single hemoglobin molecule looks like
within an RBC. Every Fe2+ is able to bind to one oxygen (O2) molecule, therefore, each
hemoglobin has the capacity to carry four O2 molecules. The binding sequence of O2 to
hemoglobin is displayed in Figure 2.
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Figure 1: Structure of a single hemoglobin molecule within an RBC containing four folded globin proteins, two alpha and
two beta chains, each connected to heme groups which carry an iron ion (Mader, 1997).

Figure 2: Schematic representation of cooperative mechanism of O2 binding to Fe2+ within hemoglobin (Hemoglobin:
portrait of a protein in action , 2012). The open circles illustrate the tetrameric structure of the hemoglobin molecule. Each
monomer binds one O2 molecule sequentially when the pO2 increases from zero on the left to fully saturated at the ambient
pO2 of approximately 160 mmHg, on the right. The arrows indicate that the bound O2 increases the hemoglobin tetramer
affinity to bind to O2, a mechanism known as “cooperative binding”.

The electron configuration of the Fe2+ bound to the hemoglobin causes an RBC to
be paramagnetic. When an O2 molecule is bound to a Fe2+ ion the hemoglobin is
diamagnetic. Unpaired electrons within the four heme groups of a deoxyhemoglobin
(deoxyHb) is what causes the RBC to present paramagnetic properties as contrasted by the
diamagnetic character of oxyhemoglobin (Zborowski, et al., 2003). As presented in Figure
3, the ferrous molecule contains two free electrons due to the ionic bonding, and when O2
is bound to the globin protein, the unpaired electrons are bound, creating a covalent bond
(Zborowski, et al., 2003).
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Figure 3: Left: Shows the ionic bonds between the ferrous molecule and globin protein. Right: Demonstrates the
configuration change when O2 is bound in resonating structures (Pauling & Coryell, 1936a).

2.2 General Magnetic Properties
There are four types of magnetization: diamagnetism, paramagnetism,
ferromagnetism, and superparamagnetism. For the scope of this paper, only diamagnetism
and paramagnetism will be analyzed for experiments, and ferromagnetism will be used to
understand how permanent magnets are utilized. For more information on
superparamagnetism, refer to ‘Introduction to Magnetic Materials’ (Cullity & Graham,
2008), ‘Four Different Types of Magnetism’ (Four different kinds of magnetism, 2016),
and ‘Magnetic Cell Separation’ (Zborowski & Chalmers, 2007). When a particle is
diamagnetic, it is repelled from a magnetic field source. It is an extremely weak form of
magnetism that is only observed when an external magnetic field is present. However, a
paramagnetic particle is weakly attracted to a magnetic field source. For example, the four
heme groups of deoxy and metHb (chemically reduced red blood cell, surrogate for deoxy
red blood cells) have unpaired electrons, which gives them paramagnetic properties
(Zborowski, et al., 2003).
To appreciate how permanent magnets in devices perform, the fundamental theory
and equations of magnetics and ferromagnetism is needed. The first property which is vital
to recognize is that all magnetic fields are the result of electrons in motion (Understanding
permanent magnets, 2015). For example, Figure 4 displays an iron atom that has an
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imbalance in the spin direction of electrons, allowing them to be transferred to and from
the atom, or to and from a spin direction, which creates an atomic magnetic dipole moment
(pm) within the atom (Understanding permanent magnets, 2015). The magnetic dipole
moment is a microscopic property of the material measured in A-m2. (Campbell, 1999).
Within a current loop, it can be calculated from the following equation:
𝑝𝑚 = IA

(2.1)

where I is the current within the loop and A is the surface area bounded by the current I,
which is coincident with the path of I. Vector quantities within equations are represented
by bold notation.

Figure 4: Imbalance of electrons within an iron atom’s electron shells (Understanding permanent magnets, 2015).

The magnetic dipole moment vector produced when electrons are coordinated
between neighboring atoms through cooperative interatomic exchange forces, determines
the ability of a material to create spontaneous magnetization and become a source of the
magnetic field in space around that material (known as a permanent magnet). The magnetic
field strength, denoted as H, and is measured in ampere-turns per meter in the International
System (SI), or in oersteds (Oe) in the gram-centimeter-second (CGS) system (Permanent
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magnet guidelines, 1998). Another description of H is depicted in Figure 5, where a
current, I, was produced by a DC battery to flow through wires to a load. The movement
of electrons in the conductor, also known as the current flow, causes a magnetic field to be
established around the wire (Understanding permanent magnets, 2015). For example, an
infinitely long solenoid produces an H field inside the solenoid, which can be calculated
by Equation 2.2 (Cullity & Graham, 2008).
H = nI1

(2.2)

Here n is the number of turns per unit length (in units of 1/m) and I1 is the current in the
conductor (measured in amperes, A).

Figure 5: Current flow within a coil resulting in a magnetic field (Understanding permanent magnets, 2015).

When a paramagnetic substance is placed inside the coil, a magnetic field is
induced, which increases the total observed field. The magnitude of the magnetic field per
unit area is known as the flux density and is measured normal to the direction of
magnetization (Permanent magnet guidelines, 1998). The flux density is denoted as B and
is measured in the CGS system as “lines” of magnetic flux, or maxwells per square
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centimeter, (one maxwell per square centimeter is equal to one gauss), while in the SI
system, it is measured in tesla (one tesla, T is equal to one weber per square meter, Wb/m2)
(Understanding permanent magnets, 2015). Equation 2.3 demonstrates that B is directly
proportional to H within a vacuum (free space).
𝑩 = 𝜇0 𝑯

(2.3)

Magnetic permeability of free space is represented by µ0. It is a constant fixed by the
definition of the electric current unit, µ0 = 4π10-7 T-m/A (Zborowski & Chalmers, 2007).
Once H and B are known for a magnetic material, a normal magnetization curve
and a hysteresis loop can be generated. The normal magnetization curve is simply the
induced flux density, B, versus the magnetizing field, H. A hysteresis loop is a more
complex curve because it demonstrates how a magnetic material reacts when an external
magnetic field is applied to it. To produce the loop, a sample material is placed between
the poles of an electromagnet, leaving a minimal air gap between the sample and the poles
(Understanding permanent magnets, 2015). Figure 6 depicts a normal hysteresis loop and
an intrinsic hysteresis loop. The difference between a normal and an intrinsic hysteresis
loop is the normal hysteresis loop compares B versus H, while the intrinsic loop compares
magnetization (J, which is described below) versus H. For permanent magnets, the first
quadrant is analyzed to learn how difficult it might be to magnetize a material to saturation
(What is the magnetic hysteresis loop, 2015). The first quadrant also corresponds to the
normal magnetization curve of a magnetic material; however, it would begin at the origin.
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Figure 6: Normal and intrinsic hysteresis loops with key properties marked (What is the magnetic hysteresis loop, 2015).

To obtain a permanent magnet, a magnetic material must be able to sustain a
magnetic flux without the presence of a coil, or outside source, which is known as a
ferrimagnet. To achieve this, exchange interaction must occur, which is the alignment of
the magnetic dipole’s axes due to the materials own internal field (Campbell, 1999).
Because an internal field exists without the presence of an applied external field, the
material is spontaneously magnetized (Campbell, 1999). When a flux density is produced
by a magnet alone it is called an intrinsic induction, magnetization (M), or magnetic
polarization (J) (units of A/m) (Understanding permanent magnets, 2015).
Magnetization yields a specific value in a designated volume of a magnet, however,
it is not likely the entire magnet will present the same, unique M throughout the material
(Campbell, 1999). Magnetization is the sum of the magnetic dipoles, pm, over the volume,
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V, shown in Equation 2.4. The description provided thus far neglects the practical
conditions which occur, such as temperature variation which would disrupt the alignment
of the moments and reduce the materials magnetization (Campbell, 1999). By rearranging
Equation 2.4, the overall magnetic dipole moment, P, is equivalent to the magnetization
multiplied by the volume of the substance being measured, shown in Equation 2.5. From
the magnetic dipole moment, the magnetic force exerted, denoted by F, is able to be
calculated from Equation 2.6. Here dB0/dx is the derivative of the flux density over the
distance at a specific point of interest.
𝐌≡

∑ 𝒑𝒎
𝑉

𝐏 = ∑ 𝐩𝒎 = 𝐌𝑉

𝐅=𝑃

𝑑𝐁0
𝑑𝐁0
= 𝑀𝑉
𝑑𝑥
𝑑𝑥

(2.4)
(2.5)

(2.6)

One way to characterize a material within a magnetic field would be to determine
the magnetic susceptibility of the material. Volumetric, magnetic susceptibility, denoted as
χ, is a dimensionless material property, which measures the response of a material to an
applied magnetic field (Borradaile, 1998), defined by Equation 2.7. To convert χ from CGS
units to SI units, it must be multiplied by 4π as shown in Equation 2.8. The conversion
factors from CGS to SI units for the mass, specific, molar, and one-gram-formula-weight
susceptibilities with their units in CGS and SI are included in Appendix A, Table X. The
magnetic susceptibility is determined experimentally by measuring the amount of force
exerted by a well-defined magnetic field on an established volume of a substance
(Zborowski & Chalmers, 2007). The magnetic force exerted can also be calculated from
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Equation 2.9, by rearranging Equation 2.7 to replace M, where H is the magnetic field
strength described above.
χ≡

𝑀
𝐻

𝜒(SI) = 4𝜋𝜒(CGS)
𝐅 = 𝜒𝑉𝐻

𝑑𝐁0
𝑑𝑥

(2.7)
(2.8)
(2.9)

Faraday designed an experiment utilizing a balance to measure the magnetic
susceptibility of different materials, which is shown in Figure 7. Part A in Figure 7
demonstrates how a paramagnetic, or ferromagnetic, material would react when placed on
the left side of the balance. Due to the magnetic field, the material would be attracted to
the field, which would mean the magnetic susceptibility of that material was greater than
zero (χ>0). Therefore, weight would need to be added to the opposite side to keep the
balance at equilibrium, and to keep the material from being pulled into the magnetic field.
However, for a diamagnetic material, it would repel out of the magnetic field causing the
magnetic susceptibility to be less than zero (χ<0). Therefore, as shown in Part B of Figure
7, weight would be added to the side with the material being tested to keep the balance at
equilibrium.

Figure 7: Schematic of Faraday’s magnetic balance used to determine the magnetic susceptibility of different materials
(Zborowski & Chalmers, 2007).
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2.3 Magnetic Susceptibility Balance
The modern-day Faraday balance, which employs the Gouy technique, is known as
a magnetic susceptibility balance (MSB). A schematic of the Gouy balance is shown in
Figure 8. This technique utilizes an electromagnet and a conventional balance. When a
sample is placed between the magnet poles, it will appear to gain weight (be attracted to
the magnet) or lose weight (be repelled from the magnet) (Magnetic susceptibility balances,
1930). As described by the Faraday balance, weight gain indicates the sample would be
ferro- or paramagnetic, while weight loss indicates a diamagnetic sample.

Figure 8: Adapted schematic of a traditional Gouy balance (Magnetic susceptibility balances, 1930).

An MSB operates with similar techniques to the Gouy balance, however, the
sample remains stationary while the magnets within the system move. Figure 9 displays a
schematic of the inside of an MSB with an image of an actual balance below it. A pair of
magnets are on opposite sides of the beam, which creates a balanced system with a
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magnetic field on each end (Magnetic susceptibility balances (MSB), 2005). Once the
sample is introduced into the magnetic field, it attempts to deflect the set of magnets closest
to it on the beam (Magnetic susceptibility balances, 1930). This movement is detected by
the optical sensors, which passes a current through a coil between the other pair of magnet
poles to produce an equal and opposite force that was exerted by the sample to return the
system to an equilibrium position (Magnetic susceptibility balances (MSB), 2005). Thus,
the current through the coil is proportional to the force exerted by the sample, and the
direction in which the beam moves indicates if the sample is paramagnetic (shown by a
plus sign on the display) or diamagnetic (shown by a minus sign on the display) (Magnetic
susceptibility balances, 1930).
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Figure 9: Above: Schematic of the inside of an MSB (Magnetic susceptibility balances (MSB), 2005). Below: Image of
the actual MSB-Auto from Dr. Zborowski’s lab at the Cleveland Clinic.
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2.4 Magnetic Separation of Labeled versus Unlabeled Cells
Magnetically labeling cells is one way magnetics is employed to separate specific
cells to be utilized for treatments and/or analyzed for a prognosis of a disease (Joshi, et al.,
2014). Biological materials have low magnetic susceptibility. To increase the highly
selective magnetostatic forces, cells are tagged with magnetic nanoparticles, which do not
interfere with the physiological electrolyte solutions used for cell suspensions and with
other cells (Zborowski, et al., 2016). However, based on a biological cell’s intrinsic
magnetic properties, labeling with magnetic nanoparticles may not be necessary, provided
the magnetic device yields a high enough magnetic field. This is an attractive alternative
to techniques which rely on immunomagnetic labeling because it eliminates the cost of
reagents and the arduous sample preparation steps of labeling the particles (Jin, et al.,
2012). Intraerythrocytic malaria parasites (Zimmerman, et al., 2006) and select cancer cell
lines have been tested and used to demonstrate the feasibility of magnetophoresis and
magnetic separation by the means of only their intrinsic magnetic susceptibility (Joshi, et
al., 2015). These types of cell separation were quantified by enrichment upon separation.
For example, Plasmodium malariae infected erythrocytes were enriched from 0.4% to
100% by means of magnetic deposition microscopy (MDM) (Zimmerman, et al., 2006).
Other examples are RBCs, which do not require magnetic nanoparticle labeling due to the
presence of unbound electrons (Zborowski, et al., 2003) creating a magnetic dipole
moment, and glioma brain cancer progenitor cells because of the increased ferritin uptake
which takes place by these cells (Kawabata, et al., 1999). In the following sections,
separation and analytical devices are presented to demonstrate how to evaluate the
magnetic susceptibility of labeled or unlabeled cells.
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2.5 Separation Devices
Magnetic cell separation and manipulation has a large impact on the development
of biotechnology engineering and is one of the fastest growing segments of cell separation
(Zborowski, et al., 2016). Two examples of high-gradient magnetic separation (HGMS)
devices are the quadrupole magnetic cell sorter (QMS) and the circular Halbach array.
These magnet arrangements are excellent tools for quantifying purity, recovery, and
throughput of sorted cell fractions. They can be utilized to separate red blood cells from
whole blood and separating cells which were magnetically labeled. ‘Continuous, intrinsic
magnetic depletion of erythrocytes from whole blood with a quadrupole magnet and
annular flow channel; pilot scale study’ (Moore, et al., 2018) and ‘Circular Halbach array
for fast magnetic separation of hyaluronan-expressing tissue progenitors’ (Joshi, et al.,
2015) provide more information on these devices.
2.6 Analytical Devices
There are numerous magnetic devices which are used to quantify the
magnetophoretic mobility (described further in Section 2.6.1) of cells, such as cell tracking
velocimetry (CTV), magnetic deposition microscopy (MDM), and magnetic flow-field
fractionation (MgFFF). Through CTV, cells are tracked with the computer program,
ImageView (described further in Section 3.4.4), to determine the average magnetic and
average sedimentation velocities of a sample. With MDM, a sample is infused into a
channel, which is placed on to a magnetic assembly, allowing the magnetic cells to deposit
on a Mylar slide and the nonmagnetic cells continue to the outlet of the channel. Lastly,
MgFFF separates cells based on different levels of magnetic material on, or within them,
and passes the fractions to an analytical device, such as a mass spectrometer. For more
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information on MgFFF refer to ‘Characterization of magnetic nanoparticles using
programmed quadrupole magnetic field-flow fractionation’ (Williams, et al., 2010).
2.6.1 Cell Tracking Velocimetry
An increasingly important technique for the diagnosis and treatment of various
cancers and diseases is cell analysis and separation (Zborowski, M., Chalmers, J., &
Moore, L. R., 2003). To help with analysis, cell tracking velocimetry (CTV) was patented
by Dr. Maciej Zborowski, Dr. Jeffrey J. Chalmers, and Lee Moore in July of 2003
(Zborowski, M., Chalmers, J., & Moore, L. R., 2003). The technique measures a labeled
or unlabeled particle’s magnetically induced velocity when placed in a magnetic field and
its settling velocity, by means of video imaging through CTV. From the settling velocity,
the size of the particle can be calculated.
There are three fundamental components along with theoretical concepts needed
for CTV. The three characteristics are a well-characterized magnetic field energy gradient,
a microscopic image acquisition system, and a computer algorithm particle tracking
velocimetry (PTV). With PTV the location and velocity of a particle can be determined in
the region of image analysis (Nakamura, et al., 2001). To begin the theoretical analysis,
the forces which act on the particle during CTV must be identified: the magnetic force
(Fm), the buoyant force (Fb), the viscous drag force (Fd), and force by gravity (Fg). From
these forces, the magnetic velocity, settling velocity, and the hydrodynamic diameter of the
particle can be determined.
Equation 2.10 demonstrates the magnetic force, Fm, depends upon three variables:
Sm (calculated from measured data), Δχ (determined from previous experiments or
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literature), and Vp, which is the volume of the particle within the sample (known by
researcher making sample) (Nakamura, et al., 2001).
𝐹𝑚 = ∆𝜒𝑉𝑝 𝑆𝑚

(2.10)

The magnetophoretic driving force, Sm, is defined by Equation 2.11, where H and B are
known from the calibration of the CTV magnet, and µ0 is the magnetic permeability
constant.
𝑆𝑚 ≡ 𝐻

𝑑𝐵 𝐵 𝑑𝐵
𝑑 𝐵2
=
=
(
)
𝑑𝑥 𝜇0 𝑑𝑥 𝑑𝑥 2𝜇0

(2.11)

The Δχ (dimensionless) is the difference between two solutions volumetric, magnetic
susceptibility calculated by Equation 2.12, which is written for the two solutions utilized
in the Sm verification experiments. This equation could also be used to determine the
magnetic susceptibility difference between a particle and a solution, where the solution
susceptibility would be subtracted from the particle’s susceptibility.
Δ𝜒 = 𝜑𝑀𝑎𝑔𝑛𝑒𝑣𝑖𝑠𝑡 𝜒𝑀𝑎𝑔𝑛𝑒𝑣𝑖𝑠𝑡 − 𝜑𝐻2 𝑂 𝜒𝐻2𝑂

(2.12)

The ϕMagnevist is the volume fraction of Magnevist (known by researcher creating the
solution), χMagnevist is the volumetric, magnetic susceptibility of the Magnevist (physical
property of substance), ϕH2O is the volume fraction of water (known by researcher creating
the solution), and χH2O is the volumetric, magnetic susceptibility of water (physical
property of substance). The difference between the magnitude of the buoyant force, Fb,,
and the gravity force, Fg, is defined as follows (Nakamura, et al., 2001):
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𝐹𝑔 − 𝐹𝑏 =

(𝜌𝑝 − 𝜌𝑓 )𝜋𝐷𝑝3 𝑔
6

(2.13)

where ρp is the density of the particle, ρf is the density of the fluid, Dp is the particle
diameter, and g is the gravity constant, which are all known from literature. Lastly, when
the Reynold’s number is less than 0.1 the viscous drag force can be assumed to be the
Stokes drag (Nakamura, et al., 2001).
𝐹𝑑,𝑥 = 3𝜋𝐷𝑝 𝜂𝑢𝑚

(2.14)

Here Fd,x is the drag force component opposing the particle motion in the um direction,
where um is the terminal magnetic velocity component in the horizontal direction (directly
measured), Dp is the particle diameter, and η is the viscosity of the fluid (known from
literature). When setting Equations 2.10 and 2.14 equal to each other, another equation for
Sm arises.
𝑆𝑚 =

18𝜂𝑢𝑚
Δ𝜒𝐷𝑝2

(2.15)

where Equation 2.12 was used to calculate Δχ between two materials.
The particle terminal velocity is calculated by equating the total force, F, with the
viscous drag force (Xue, et al., 2019):
𝐹 = 𝐹𝑑

(2.16)

where F is also the vector sum of the magnetic component, Fm, (acting in the horizontal,
x-axis direction) and the Fg – Fb component (acting in the vertical, y-axis direction), so that
in the vertical direction the following expression for the drag force applies:
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𝐹𝑑,𝑦 = 3𝜋𝐷𝑝 𝜂𝑣

(2.17)

The particle terminal velocity vector has two components, in the horizontal (x-axis)
direction and vertical (y-axis) direction. From the foregoing equations, terminal velocity
magnetic and sedimentation components are, respectively (Xue, et al., 2019):
𝑢𝑚 =

𝑣=

𝜒𝑐𝑒𝑙𝑙 − 𝜒𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 𝑉𝑐𝑒𝑙𝑙
𝑆
3𝜋𝜂
𝐷𝑐𝑒𝑙𝑙 𝑚

(2.18)

𝜌𝑐𝑒𝑙𝑙 − 𝜌𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 2
𝐷𝑐𝑒𝑙𝑙 𝑔
18𝜂

(2.19)

where um is the experimentally determined mean magnetic velocity in units of m/s, v is the
experimentally determined sedimentation velocity in units of m/s, and the other variables
follow the same notation stated within this section. The particle magnetophoretic mobility,
m, is defined as the ratio of its magnetic field-induced velocity, um, and the
magnetophoretic driving force, Sm:
𝑚=

𝑢𝑚
𝑆𝑚

(2.20)

These equations provide the theoretical foundation for CTV.
The well-defined magnet assembly, Mk V, which has been utilized in many other
experiments, is the strongest magnet created for CTV research (Xue, et al., 2019). Within
the FOV, the magnetostatic potential energy gradient, Sm, is horizontal, nearly constant,
and well-characterized due to the hyperbolic pole pieces within the system, which occurs
in the microscopes FOV (Xue, et al., 2019). Figure 10 Part A represents the section of the
CTV system where the cell suspension is contained by a glass channel, which is located
inside the magnet assembly (Xue, et al., 2019). The magnetostatic potential energy density
gradient should be as constant as possible to avoid any variation in the magnetic field
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presented to the particles within the FOV. Figure 11 represents a predicted model of the
Mk V magnet flux density field B in units of Tesla (T) (blue dotted line), with a best fit
line corresponding to the flux density (black line), the gradient of the B field (red line), and
twice the product of the magnetic flux density field and the gradient of the flux density,
dB2/dy (green line), which is proportional to Sm. Here the Sm graph is nearly constant within
the FOV, which would allow for the particles to be exposed to the most uniform magnetic
field possible. This is important in order to characterize the magnetic properties of the
particles appropriately within the CTV system. If the magnetic field within the FOV is
constant, or nearly constant, the particles will have a magnetic velocity which is
independent of the particle location within the system.

Figure 10: Image of the CTV magnet with explanations. A) Photograph of portion of permanent magnet showing
hyperbolic shape of pole pieces with the glass channel colored red, B) Composite diagram of equipotential and field lines
(top) and magnetostatic potential isolines and force vectors (bottom) C) Expected outcomes for deoxygenated RBCs (top)
and oxygenated RBCs (bottom) (Xue, et al., 2019).
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Figure 11: Key CTV magnetostatic field parameters (Xue, et al., 2019).

The computer algorithm needed to perform CTV mentioned above originated from
a 3-D version of particle tracking code, known as particle tracking velocimetry (PTV)
(Nakamura, et al., 2001). PTV utilized five successive images to predict the most probable
pathway for a specific particle (Nakamura, et al., 2001). The original PTV algorithm was
developed for 3-D flow visualization studies of complex hydrodynamic flow where
hundreds of instantaneous velocities at different locations were wanted, and does not report
particles tracked from frame to frame (Nakamura, et al., 2001). For CTV, the algorithm
was modified to provide these reports in which the location and velocities of specific
particles are presented for a series of frames, which is determined by the user (Nakamura,
et al., 2001). This algorithm will be described in length in Chapter III – Materials and
Methods.
2.6.2 Magnetic Deposition Microscopy
Magnetic cell separation was propelled to the forefront of separation techniques
due to the rapidly growing demands in cell biology and clinical laboratories (Zborowski,
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et al., 2016). The prototype of MDM was known as the Bio-Ferrograph, which was
developed in collaboration with the Institute Guilfoyle in Belmont, MA and Bingbing
Fang, Dr. Maciej Zborowski, and Lee Moore from the Department of Biomedical
Engineering at the Cleveland Clinic (Fang, et al., 1999). A few of the first cell-types
separated utilizing MDM (Bio-Ferrograph) were MCF-7 breast cancer cells and malaria
cells from whole blood.
Applications of MDM are known to pull weakly magnetic cells from a flowing cell
suspension due to the high magnetic gradient generated by the magnets within the
assembly. The magnetic cells are deposited onto a transparent, thin sheet of Mylar, which
can be analyzed under a microscope. More information about the magnet assembly can be
found in ‘Magnetic separation of algae genetically modified for increased intracellular iron
uptake’ (Buck, et al., 2014).
A theoretical analysis of the MDM is similar to CTV because the magnetic force,
the viscous drag force, and the magnetic velocity are calculated from the same equations,
Equation 2.10, 2.14, and 2.18, respectively (Moore L. R., et al., 1998). However, the
microfluidic fluid velocity profile between CTV and MDM are different. The following
equation approximates the velocity profile given by Purday (Moore L. R., et al., 1998):
𝑛

|𝑦|
𝑥 2
𝑤 = 𝑤𝑚𝑎𝑥 (1 − ( ) ) (1 − ( ) ) ;
𝑎
𝑏

|𝑥| ≤ 𝑎, |𝑦| ≤ 𝑏

(2.21)

The cell velocity is represented by w, wmax is the maximum cell velocity, x and y are
distances from the channel center, a is the half-depth of the channel, b is the half-width of
the channel, and n is a constant that depends on the aspect ratio of the channel, b/a. It can
be calculated by Equation 2.22 (Moore L. R., et al., 1998).
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𝑛(𝑛 + 1) =

2𝑏 2
𝑎2

(2.22)

Once n is known, the relationship between wmean and wmax can be determined by Equation
2.23 and wmean is given by Equation 2.24 (Moore L. R., et al., 1998).
𝑤𝑚𝑎𝑥
3(𝑛 + 1)
=
𝑤𝑚𝑒𝑎𝑛
2𝑛

𝑤𝑚𝑒𝑎𝑛 =

𝑄𝑜
𝐴

(2.23)

(2.24)

Here Qo is the volumetric flow rate entering the channel and A is the surface area of the
channel.
Below, Figure 12 provides three important aspects to the MDM setup. Part A
displays a color map, with graduations of 0.08 T, of the magnetic field generated by the
magnetic assembly (Buck, et al., 2014). At the edges of the two interpolar gaps, the blue
rectangles, there are four spots where the magnetic field exceeds 1.4 T and the gradient
exceeds 1,000 T/m, at the corners of the interpolar gaps (Buck, et al., 2014). Part B presents
a graph which verified the field map compared to the magnitude of the magnetic field along
the y-axis at x=0 (Buck, et al., 2014). The last part of Figure 12 is Part C, which represents
all the components of the experimental setup. The magnet assembly is labeled 1, the Mylar
slide is denoted as 2, while 3 is the silicon rubber gasket with five flow channel cutouts, 4
is the manifold with the inlet at the bottom connected to the sample vial by tubing and the
outlet at the top linked to the syringe pump also by tubing, and lastly 5 is the platen which
holds all of the parts together against the magnet (Buck, et al., 2014). Figure 13 is an image
of the fully assembled MDM system displayed in Part C of Figure 12.
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Figure 12: (A) Color map of the magnetic field with color graduations of 0.08 T, (B) Verified the magnitude of the
magnetic field represented by the color map in A along the y-axis with x=0, (C) Represents all of the parts used to
assemble the MDM to complete an experiment (Buck, et al., 2014).
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Figure 13: 1) 1 mL vials containing sample solutions. 2) Microfluidic tubing connecting the sample to the channel against
the magnet. 3) Fully assembled MDM system presented in Part C in Figure 12 along the y-axis. 4) Second set of
microfluidic tubing connecting the channel to the syringes. 5) Three-way Hamilton valves allowing the sample to move
from the channel to the syringes. 6) 1 mL syringes collecting the sample solution. 7) Legato 210P multi-syringe kd
Scientific syringe pump, withdrawing the sample into the syringe and infusing the sample back into the sample vial.
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2.7 Cooperative Binding of Oxygen and Hemoglobin: Adair and Hill Equations
Red blood cell saturation by oxygen depends on the pO2 in the solution and is
described by Adair’s equation illustrated by the oxygen-hemoglobin equilibrium curve in
Figure 14. This is also demonstrated in Figure 15, where fully oxygenated RBCs (low spin)
present a diamagnetic magnetic mobility, whereas fully deoxygenated RBCs (high spin)
display a more paramagnetic response in the presence of a magnetic field (Zborowski, et
al., 2003). The number of cells tracked is denoted by n, and magnetic mobility is denoted
by m.

Figure 14: Graph of the oxygen-hemoglobin equilibrium curve generated in Maple by Dr. Zborowski. Graph of the
fractional concentrations of five hemoglobin-O2 complexes (left axis), and the corresponding hemoglobin-O2 equilibrium
curve (right axis) as a function of pO2 calculated from the Adair equation. Symbols nB describe the number of heme
groups that contribute to the paramagnetic dipole moment of the hemoglobin-O2 complex.
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Figure 15: Magnetophoretic mobility of oxygenated and deoxygenated RBCs. The graph on the left represents fully
oxygenated RBCs, while the graph on the right displays fully deoxygenated RBCs (Zborowski, et al., 2003).

Adair’s generalized equation is stated in Equation 2.25, where S is the fractional saturation,
p is the oxygen pressure, an are the overall Adair parameters, which are determined
experimentally, and n corresponds to the number of oxygen molecules bound to the
hemoglobin within the RBCs (Winslow, et al., 1977). The Kn parameters are the stepwise
Adair constants, which refer to a specific binding scheme of oxygen to hemoglobin and the
simplest way to describe the binding scheme (Imai, 1994). Theoretical values for the
stepwise Adair’s coefficients are found in Table I.
S=

𝑎1 𝑝 + 2𝑎2 𝑝2 + 3𝑎3 𝑝3 + 4𝑎4 𝑝4
4(1 + 𝑎1 𝑝 + 𝑎2 𝑝2 + 𝑎3 𝑝3 + 𝑎4 𝑝4 )

𝐾1 𝑝 + 3𝐾1 𝐾2 𝑝2 + 3𝐾1 𝐾2 𝐾3 𝑝3 + 3𝐾1 𝐾2 𝐾3 𝐾4 𝑝4
=
1 + 4𝐾1 𝑝 + 6𝐾1 𝐾2 𝑝2 + 4𝐾1 𝐾2 𝐾3 𝑝3 + 𝐾1 𝐾2 𝐾3 𝐾4 𝑝4 )

(2.25)

Also, S is the fractional saturation of oxyhemoglobin, which influences RBC
magnetophoresis by determining the magnetic susceptibly of an RBC. Equation 2.26
demonstrates how the fractional saturation levels influence the susceptibility of an RBC.
𝜒𝑅𝐵𝐶 = 𝜑H2O 𝜒H2 O + (1 − 𝑆)𝜑Hb 𝜒deoxyHb + 𝜑globin 𝜒globin

(2.26)

The volume fraction of water, deoxyhemoglobin, and the globin protein are denoted as
ϕH2O, ϕHb, and ϕglobin, respectively. The volumetric, magnetic susceptibility of these species
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are χH2O for water, χdeoxyHb for deoxyhemoglobin, and χglobin for the globin protein. Utilizing
these definitions, varying the fractional saturation of the RBC solution, and evaluating the
volumetric, magnetic susceptibility at those fractional saturation values by means of the
CTV deoxygenation system, it will be determined if the oxygenation level of an RBC can
be measured through magnetophoresis.
Table I: Form-specific Adair’s Coefficients (Matejak, et al., 2015).

Estimated Form-Specific Adair’s Coefficients
Coefficient

Value

Units

K1
K2
K3
K4

0.0121
0.0117
0.0871
3.8610-4

mol/m3
mol/m3
mol/m3
mol/m3

The Hill equation, stated in Equation 2.27, was originally formulated by Archibald
Hill in 1910 to describe the sigmoidal curve of oxygen binding to hemoglobin (Hill, 1910).
Here Y is the fractional saturation of oxygen bound to the hemoglobin, x corresponds to the
log of the Gaussian b-value, k is 10 raised to the negative value of the y-intercept from the
regression line of the linearized Hill equation, and n is the Hill coefficient, also known as
the slope of the regression line of the linearized Hill equation. This will be discussed further
in Section 3.4.6. For the purpose of this study, the Hill equation was considered a
satisfactory approximation of a more complex Adair equation in applications to analyze
the RBC magnetophoresis data.
𝑥𝑛
𝑌=
𝑘 + 𝑥𝑛
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(2.27)

2.8 Spectrophotometry
There are many applications within the life sciences for spectrophotometry outside
of a classroom. For example, it could be used to determine the number of cells within a
suspension. For the interest of the research being presented in this paper, it was utilized to
determine the concentration of oxyhemoglobin and methemoglobin within a blood sample.
This is done by measuring the amount of light which passes through or is absorbed by a
sample (Bostick, 2018). Spectrophotometry follows two basic principles. First, every
substance transmits or absorbs specific wavelengths of energy (Bostick, 2018). Second,
depending on the amount of material dissolved within the sample solution (known as an
analyte), the measured intensity of the color will vary, allowing the concentration of a
substance to be determined within the sample (Bostick, 2018). Figure 16 represents a
general overview of what occurs within a spectrophotometer. An initial known intensity of
light, I0, is passed through the sample, and a different intensity, I, is measured by the
photocell on the opposite side of where the initial light entered the sample. Equation 2.28
is then utilized to calculate the transmittance of the sample, T.

Figure 16: Adapted schematic of what occurs within a spectrophotometer (Bostick, 2018).
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𝑇=

𝐼
𝐼0

(2.28)

Another way to interpret the intensity of light within a sample is with the absorbance, A.
This value can be calculated with Equation 2.29.
𝐴 = − 𝑙𝑜𝑔 𝑇

(2.29)

Christine Winterbourn determined that different forms of oxygen-hemoglobin
compounds present different absorbance levels when a spectrum of 500 – 700 nm
wavelengths are passed through the sample (Winterbourn, 1990). Specifically,
Winterbourn

focused

on

oxyhemoglobin,

methemoglobin,

and

hemichrome.

Oxyhemoglobin (oxyHb) is the form of hemoglobin where all eligible binding sites of the
hemoglobin molecule have an O2 molecule bound, therefore, there are no unpaired
electrons. Methemoglobin (metHb) is formed by chemically reducing oxyHb with sodium
nitrite (NaNO2). Hemichromes form by methemoglobin having an unstable globin
structure, which allows for the distal histidine or an external ligand to bind to heme
(Winterbourn, 1990). Chemical reactions presented in Equations 2.30 and 2.31 represent
how oxyHb turn into metHb and metHb revert to oxyHb, respectively.
2H ∓ + O−
2 + oxyHb → metHb + O2 + H2 O2

(2.30)

−
O−
2 + metHb → oxyHb + 2𝑒

(2.31)

It is known that reactions can be followed spectrally, and with this information
Winterbourn developed equations to calculate the concentration, in units of µM, of
oxyhemoglobin, methemoglobin, and hemichrome within a blood sample, presented in
Equations 2.32, 2.33, and 2.34, respectively. The Ai variables denote the absorbance value
at the i wavelength.
[Oxyhemoglobin] = 119𝐴577 − 39𝐴630 − 89𝐴560
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(2.32)

[Methemoglobin] = 28𝐴577 + 307𝐴630 − 55𝐴560

(2.33)

[Hemichrome] = −133𝐴577 − 114𝐴630 + 233𝐴560

(2.34)

At each of these absorbance levels there are certain attributes which allowed for a
distinction between the different hemoglobin types. For wavelength 577 nm, oxyHb
presents a sharp rise to a second peak (Winterbourn, 1990). MetHb presents a characteristic
peak or shoulder at wavelength 630 nm (Winterbourn, 1990). Lastly, hemichrome is shown
by a shallower trough at 560 nm within oxyHb-metHb mixtures (Winterbourn, 1990).
Figure 17 displays the spectra of Hb, oxyHb, and metHb from 450 – 700 nm.

Figure 17: OxyHb and metHb absorbance curves from 450 - 700 nm (Giangreco, et al., 2013).
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2.9 Glioblastoma
Glioma is a tumor occurring within the brain and spinal cord stemming from glial
cells (Glioma, 2019). Glial cells are brain cells which support nerve cells (Glioma, 2019).
There are three types of glial cells which can form into tumors, and the gliomas are
classified by the type of glial cell that produced the tumor (Glioma, 2019). By knowing the
glial cell which caused the glioma, it can help predict how the tumor will act over time and
what treatments would be the most effective (Glioma, 2019). The three types of glial cells
which form into gliomas are: astrocytomas, ependymomas, and oligodendrogliomas
(Glioma, 2019). Astrocytomas gliomas include astrocytoma, anaplastic astrocytoma, and
glioblastoma (Glioma, 2019). Anaplastic ependymoma, myxopapillary ependymoma, and
subependymoma are categorized as ependymomas gliomas (Glioma, 2019). Lastly,
oligodendrogliomas contain oligodendroglioma, anaplastic oligodendroglioma, and
anaplastic oligoastrocytoma (Glioma, 2019). For the

purpose of this paper, only

glioblastoma will be expanded upon. For more information about astrocytomas,
ependymomas, and oligodendrogliomas see references ‘Glioma: Astrocytoma’ (Glioma:
Astrocytoma, 2019), ‘Brain tumor: Ependymoma’ (Brain tumor: Ependymoma, 2019), and
‘Glioma: Oligodendroglioma’ (Glioma: Oligodendroglioma, 2019), respectively.
Glioblastoma, or glioblastoma multiforme (GBM), is classified by the World
Health Organization (WHO) as a grade IV glioma. It is the most common and lethal brain
tumor in adults and accounts for 45% of all malignant brain tumors (GBM agile: A
revolutionary new adaptive trial platform, 2019). The median survival rate upon diagnosis
is about one to two years, and 95% die within five years (GBM agile: A revolutionary new
adaptive trial platform, 2019). Different forms of treatment are surgery, radiation,
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chemotherapy, tumor treating fields, and targeted drug therapy (Glioma: Glioblastoma,
2019). However, a cure is not often possible for GBM. Due to consistent poor prognoses
for patients with this aggressive and persistent brain tumor, the hopes of developing new
and more effective treatments are being explored.
It was stated that cancer stem cells (CSCs) could be the reason that GBM is violent
and relentless (Lathia, et al., 2015). The ability to self-renew and give rise to a
differentiated progeny is the definition of a CSC (Lathia, et al., 2015). Their functional
characteristics are they can generate a tumor when transplanted for a second time into a
body containing cellular heterogeneity and progeny with fluctuating degrees of selfrenewal capabilities (Lathia, et al., 2015). The term ‘stem cell’ does not imply the cells
formed from altered stem cells, because there is evidence that multiple cell types are
susceptible to form cancerous cells (Lathia, et al., 2015). Efforts to identify and isolate
CSCs have been difficult. Surface markers, like SOX2, CD133, and CD44, have been used
to identify CSCs, which is then coupled with cytometry to separate them. This method of
isolation has contributed to the research progress of CSCs (Duan, et al., 2013).
It is known that CSCs thrive in stressful conditions, such as hypoxia, low glucose,
inflammation, oxidative stress, and acidic stress (Schonberg, et al., 2015). For all these
situations, iron metabolism enables the effects and growth of CSCs (Schonberg, et al.,
2015). A direct source of CSC resistance to therapy and tumorigenicity may be uncovered
by exploiting the abnormal iron regulation within these combinations of conditions within
tumors (Schonberg, et al., 2015). It was hypothesized that CSCs in GBM search out iron
within regulatory functions within the body typically for the liver and specific regions of
the brain, like choroid plexus, for the transferrin consumption and excretion, which
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increases the intracellular iron concentrations of CSCs (Schonberg, et al., 2015).
Transferrin (TF) is the primary iron storage protein and iron metabolism within the body
(Brem, et al., 2006).
An important observation made by Schonberg, et al., was within an ex vivo
transplant model and a 3D reconstruction of TF co-localization of a tumor cell surface,
demonstrated that more than 20-fold higher amount of TF were bound to CSCs than nonCSCs in the same conditions. Also, an increased level of transferrin receptors (TfRs) was
detected (Schonberg, et al., 2015). The prime path for iron uptake necessitates ferric iron
(Fe3+) to bind to TF and attach to TfRs on the cell membrane. Many cancers, such as
bladder, breast, glioma, leukemia, lung, and lymphoma, express abnormally high quantities
of TfRs, which in turn suggests that tumor cells display a high demand for iron (Schonberg,
et al., 2015). From this information, it is apparent that TfR activity plays a part in tumor
growth (Schonberg, et al., 2015). Iron bound to hemoglobin is one of the most common
types of iron within the human brain (Brem, et al., 2006). The upregulated iron trafficking
in GBM CSCs indicate they may possess intrinsic magnetic potential, which means CSCs
exhibit nearly paramagnetic properties (Brem, et al., 2006). Through CTV, MDM,
cytosmears, and fluorescent staining, it was investigated if CSCs could be differentiated
and separated from other types of brain progenitor cells. Further explanation of the
materials used for these experiments are described in Section 3.5.1.
2.10 Giddings Velocity Profile
When separating out viable RBCs for use in transfusions, scaling up the process
from small amounts of blood, ~15 mL to 1 L, is always being explored. An idea which was
considered was to couple magnetic separation with a temperature gradient being applied to
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the sample suspension. J. Calvin Giddings developed a temperature gradient velocity
profile, which would facilitate separation between two species by means of natural
convection. For example, when a pot of water is placed on a stove top to boil, the water at
the bottom heats up causing the density to drop. It then rises to the top of the pot, while the
cooler water, with a higher density, moves to the bottom to replace it. Figure 18 represents
an example of a velocity profile within a thermogravitational column.

Figure 18: Representation of the Giddings velocity profile with a temperature gradient within the fluid (Giddings, 1991).

This velocity profile, v(y), can be calculated from Equation 2.35.
𝑣(𝑦) =

𝜌𝛾𝑔𝑤 2 Δ𝑇 𝑦
𝑦
2𝑦
(1 − ) (1 − )
12𝜂
𝑤
𝑤
𝑤
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(2.35)

Here ρ is the density, γ is the thermal expansion coefficient, g is the gravitational constant
of 9.81 m/s2, ΔT is the temperature difference between the hot wall and the cold wall, η is
the viscosity of the fluid, y is the distance from the cold wall, and w is the width of the
channel. Parameters ρ, γ, and η were evaluated for the fluid at the cold wall. Decreasing
the viscosity of the fluid, having a larger temperature difference between the hot and cold
walls, and increasing the channel thickness would increase convective flow to facilitate
separation (Giddings, 1991).
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CHAPTER III
MATERIALS AND METHODS
3.1 Determination of the Magnetophoretic Driving Force for the Cell Tracking
Velocimetry Magnet Assembly
3.1.1 Materials
Polystyrene (PS) particles of 2.7 µm nominal diameter were synthesized in
Professor Shlomo Margel’s Laboratory in the Department of Chemistry at Bar-Ilan
University located in Ramat Gan, Israel in 2000 (Moore L. R., et al., 2000). They were
originally measured to have a radius of 1.35 ± 0.02 µm, as evaluated by a sub-micron
particle analyzer (model N4MD, Coulter Electronics Ltd., Luton, UK), and a volumetric
susceptibility of -8.2110-5 (SI units). These were kept in a powder form and stored at room
temperature. Their radius was re-evaluated upon reconstitution in buffer solution with a
Beckman-Coulter Multisizer 4e by Mitchell Weigand in Dr. Jeffrey Chalmers Lab at The
Ohio State University in Columbus, OH, to have a mean radius of 1.42 ± 0.02 µm. The
particles were tested in a 0.5 M Magnevist in MDM buffer solution. MDM buffer is a
mixture of 0.1% weight/volume Pluronic F-68 (Sigma Aldrich), 2 mM EDTA (Sigma
Aldrich), and 0.02% weight/volume Sodium Azide (NaN3) (Sigma Aldrich) in 100 mL of
10PBS (Phosphate Buffer Solution) free of calcium and magnesium (Cleveland Clinic
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Main Campus Media Core Services). A Vortex Genie-2 (Scientific Industries, Bohemia,
NY) was operated to mix the particles, MDM buffer, and Magnevist.
Two three-way Hamilton valves were utilized, intended to be chemically inert, with
plug type ‘T’, with polytetrafluoroethylene (PTFE) and Kel-F flow path, rated for 100 psig.
Male chromatography fittings (¼-28  1/16”) were used with poly ether ether ketone
(PEEK) tubing (1/16” OD  0.02” ID; Upchurch Scientific) to connect to the square
borosilicate glass channel (1.4 mm OD  1.0 mm ID; VitroCom #8100). Figure 19 is an
image of the assembly itself. Approximately 2 cm of 1/16” ID silicone tubing was utilized
to interface the PEEK tubing to the glass channel and wrapped with 28 AWG bare copper
wire to secure the seal. Phar-Med (LS-16, Saint-Gobain) was placed over the silicone
tubing and secured with 4” wire ties to minimize oxygen transport to the sample within the
tubing. Connected to the Hamilton valves were two 5 mL B-D disposable, plastic syringes
by means of a ¼-28 male-to-female Luer adaptors from Upchurch Scientific. These
materials were utilized to facilitate flow of the sample solution during experiments.
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Figure 19: Picture of the CTV system utilized for the Sm verification experiments.

For the CTV setup, a 5 objective lens (LMPlanFl, Olympus, Japan), 3.3 photo
eyepiece (U-PMTVC, Olympus, Japan), and CCD camera (Retiga 200R, QImaging,
Canada) were used to capture the images of the particle motion within the magnetic field
through the Video Savant 4 software (Xue, et al., 2019). This software allows the user to
select the region of interest (ROI), gain, exposure time, frame rate, number of images in a
set, and the image file type (*.RAW). The PC utilized was a Dell OptiPlex 980 with an
Intel Core I7 280 GHz processor, 8.0 GB RAM, and 64-bit Win7 Pro OS. The camera and
the computer are connected by firewire (IEEE 1394) cable to a firewire card installed in
the PC.
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A solution with a well-defined magnetic susceptibility (Δχ) was utilized, made up
of polystyrene beads, Magnevist®, and magnetic deposition microscopy (MDM) buffer.
Magnevist is a gadolinium magnetic resonance imaging (MRI) contrast agent made by
Bayer AG (Magnevist®, 2017), and its systematic name is gadopentetate dimeglumine
(C28H54GdN5O20), which has a similar volumetric, magnetic susceptibility to gadolinium
at 7.5810-5 (SI) (Lide, 2005). Due to the paramagnetic susceptibility of the Magnevist, the
diamagnetic PS particles should move away from the magnet indicating a significant
diamagnetic component relative to the Magnevist/MDM buffer solution. Equation 2.12
was used to determine the magnetic susceptibility of the solution, difference between the
Magnevist and the MDM buffer, which is similar to water at -9.03510-6 (SI).
3.1.2 Methods
To begin, 1 g of PS particles was weighed and added to a 15 mL Falcon tube (Fisher
Scientific) with 10 mL of MDM buffer. Then 40 µL of the PS particles were pipetted into
a 15 mL Falcon tube (Fisher Scientific), followed by 5 mL of Magnevist, and 5 mL of
MDM buffer for a concentration of ~100,000 PS particles/mL. The solution was then
vortexed on the Genie-2 for 15 – 30 seconds at the highest setting of 10 at room temperature
to ensure the solution was well-mixed. Next, part of the solution was drawn into a 5 mL
syringe and it was attached to the Luer adaptors connected to the Hamilton valve on one
end of the CTV channel. An empty syringe was attached to the Hamilton valve on the
opposite side of the channel. This is displayed by the schematic in Figure 20.
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Figure 20: Schematic of the empty syringe on the left and full syringe on the right attached to the Hamilton valves.

The Hamilton valves were turned to allow for the sample to be pushed through the channel
to the empty syringe. About 0.2 mL of sample was pushed through the channel over a time
frame of 3 seconds, the Hamilton valves were closed to stop fluid flow, and it was given
30 seconds of relaxation time before recording the motion of the particles. Next, the record
button in the Video Savant software was pressed to begin recording for 60 frames at a
frame rate of 1 second, totaling a minute of acquisition time. Once the recording was
completed, the images were reviewed to ensure the particle’s motion were uniform in
velocity and direction, and they were saved according to the nomenclature specified by the
CTV logbook as set one. This process was repeated 11 times, over a time span of 25 – 30
minutes, for a total of 12 sets for the FOV position at a designated distance of 4 mm from
the edge of the magnet. The additional three positions, 4.5, 5, and 5.5 mm from the edge
of the magnet, as seen in Figure 21, were tested through the same procedure to verify the
Sm value for the system.
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Figure 21: Edge of the CTV magnet in the center of the FOV within Video Savant.

3.1.3 MSB-Auto Methods to Measure the Magnetic Susceptibility of the MDM Buffer
and Magnevist Solution
To ensure the magnetic susceptibility found in literature was accurate for MDM
buffer and Magnevist, the solutions were verified with the MSB-Auto. Each experiment
began by measuring an empty MSB Auto tube in order to account for the magnetic
susceptibility of the tube itself, displayed in Figure 9. Next, the MSB Auto machine was
turned on and given time to tare to zero before placing the empty tube into the measuring
slot. Once the empty tube was measured, the range button was pressed to scale the value
shown on the screen by a multiple of ten, to go from the 10-4 V range to the 10-5 V range.
The unit V is used to represent the volumetric magnetic susceptibility in CGS units,
cm3/mol or cm3/g. The range button is pressed again to scale the value to the 10-6 V range,
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and finally one last time to scale to the 10-7 V range. The value displayed on the screen,
was the value recorded as the volumetric, magnetic susceptibility. This was repeated four
times, for a total of five readings for the empty tube. Next, the 50/50 mixture of the MDM
buffer and Magnevist solution was tested. About 200 µL was pipetted into the empty tube,
which was just measured, to reach a height of about 1.5 cm from the bottom of the tube.
Measurements for the solution were obtained the same way as the empty tube, but the range
button was only pressed twice instead of three times due to an overflow error when it was
pressed a third time. Just like the empty tube, the solution sample was measured for a total
of five readings. This procedure was also completed for pure Magnevist, pure MDM buffer,
0.25 mL of Magnevist in MDM buffer, 0.125 mL of Magnevist in MDM buffer, 0.0625
mL of Magnevist in MDM buffer, and 0.03125 mL of Magnevist in MDM buffer.
3.2 Spectrophotometry
3.2.1 Materials
A 5 mL tube of whole blood with a pink top was obtained from the Pathology Lab
at the Cleveland Clinic Main Campus Hospital. The pink top tube contains dipotassium
ethylenediaminetetraacetic acid (K2EDTA) to prevent the blood from coagulating until it
can be tested by the Pathology Lab. The Institutional Review Board (IRB) regulations were
followed for these samples to protect the rights and welfare of the person whose blood was
used (Cleveland Clinic IRB #10-1064: EXEMPT. Magnetophoretic Cell Sorting and
Analysis, P.I.: Maciej Zborowski). This blood was used to make metHb (made with 1PBS
and sodium nitrite, NaNO2) and oxyHb to be tested within the spectrophotometer. Samples
were placed in a 1.5 mL acrylic cuvette from VWR International (Radnor, Pennsylvania)
to be measured in the Beckman Coulter DU® 730 Spectrophotometer (Brea, California).
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Specifications for the spectrophotometer are in Appendix A, Table XI, while an image of
the spectrophotometer and cuvette are displayed below.

Figure 22: Spectrophotometer by Beckman Coulter and cuvettes by VWR utilized for the spectrophotometer experiments.

The samples were washed with 1PBS, made from 10PBS and MilliQ water (double
deionized water, Cleveland Clinic, LRI), in 15 mL Falcon tubes (Fisher Scientific) in the
Beckman Coulter Allegra™ 6R Centrifuge (Brea, California). The last material utilized for
these experiments was distilled water obtained from the house line at the Cleveland Clinic,
LRI building.
3.2.2 Methods
Before samples were made, 1 L of 1PBS was made by mixing 100 mL of 10PBS
(Cleveland Clinic Media Core) and 900 mL of MilliQ water in a 1 L Pyrex bottle. Next,
metHb was prepared by mixing 0.0119 g of NaNO2 with 10 mL of 1PBS in a 15 mL
Falcon tube. This was then mixed with the Vortex Genie-2 at the highest setting to ensure
the solution was well mixed. After, 50 µL of whole blood was added to the mixture and set
into an incubator at 37°C for 30 minutes to allow for the RBCs to convert to metHb. While
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the metHb was forming, 50 µL of whole blood was added to another 15 mL Falcon tube
with only 10 mL of 1PBS to create oxyHb. Then, the oxyHb sample was washed with
1PBS three times at 1,500 rpm for 5 minutes to guarantee all the white blood cells,
platelets, and other residual components from the whole blood were removed from the
sample. After each wash, the supernatant was removed and discarded in the biological
waste container. When the metHb sample was done incubating, it was also washed the
same as the oxyHb sample. Once the samples were ready to be tested, 1 mL of distilled
water was pipetted into two cuvettes, and then 0.3 mL of the oxyHb was added to one and
0.3 mL of the metHb was added to the other. One cuvette was measured in the
spectrophotometer at a time over the range of 500 – 700 nm. The spectrums for each sample
and concentration calculations completed utilizing Equations 2.32 – 2.34 are displayed and
discussed in Chapter 4.
3.3 Modifications made to the Cell Tracking Velocimetry System for the
Deoxygenation of Red Blood Cells
Before experiments of magnetophoresis of RBCs at different deoxygenation levels
could begin, the CTV system utilized to determine Sm had to be modified. A schematic of
the original setup is in Figure 23. In order to modify the system, tubing had to be connected
to allow for gas flow into the deoxygenation vessel and for sample flow from the vessel to
the syringes for image acquisition. Therefore, Figure 23 was modified to account for these
needed changes and the schematic of the system is found in Figure 24 and an image of the
setup is in Figure 25 with a closeup image of the magnet assembly in Figure 26. For more
information about each component, refer to Section 3.1.1 and 3.4.1.
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Figure 23: Adapted schematic of original CTV setup (Xue, et al., 2019).

Figure 24: Modified CTV setup for the deoxygenation of RBC experiments (Xue, et al., 2019). 1) Flow meters utilized to
regulate the compressed air and compressed N2 to the system. 2) Humidifier to wet the gases. 3) Stir bar placed in the
deoxygenation vessel and the Fisher Scientific Lab Disc Magnetic Stirrer placed under the vessel to ensure the system is
well-mixed. 4) Deoxygenation vessel and sample solution inside it. 5) N2 bleed-off tubing. 6) RDO® Rugged Dissolved
Oxygen (DO) Sensor and Orion Star A213 Dissolved Oxygen Meter. 7) NOx tubing connecting the deoxygenation vessel
to the syringes for sample measurement. 8) Mk V magnet assembly. 9) PEEK tubing connecting the syringes with the
sample to the glass channel which runs through the magnet assembly itself to the other syringe. 10) 10 mL glass syringes
(made by Hamilton) which protects the sample from oxygen penetration.
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Figure 25: Full CTV setup for deoxygenation experiments.

Figure 26: Magnet assembly with glass syringes, and Hamilton valves.
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Previous experiments analyzing the magnetic mobility of fully deoxygenated RBCs
completed by Dr. Wei Xue, (Xue, 2016) utilized a different DO probe and meter. For the
experiments done here, the RDO® Rugged Dissolved Oxygen sensor (Thermo Scientific,
Waltham, MA) and Orion Star A213 Dissolved Oxygen Meter (Thermo Scientific,
Waltham, MA) were used. Specifications and dimensions of the probe are in Appendix A,
Tables XIV and XV, respectively, while specifications for the meter are in Appendix A,
Table XVI. Figure 27 below displays images of the meter and probe.

Figure 27: Left: Orion Star A213 dissolved oxygen meter from Thermo Scientific. (Component number 7 in Figure 25)
Right: Orion™ RDO® Rugged Dissolved Oxygen sensor from Thermo Scientific. (Component number 6 in Figure 25)

Along with the new DO probe and meter, a new deoxygenation vessel was designed
to meet the required minimum immersion depth of the probe to measure the dissolved
oxygen saturation of the sample solution. This was completed within SolidWorks,
developed by Dassault Systèmes, in collaboration with Principal Research Engineer, Lee
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Moore at the Lerner Research Institute at the Cleveland Clinic Main Campus, and 3Dprinted. Rob Geszler operated a PolyJet printer (Stratsys, Eden Prairie, MN) with
VeroClear resin, which is optically translucent with ABS-like mechanical properties to 3Dprint the vessel. A schematic of the new deoxygenation vessel is shown in Figure 28 with
the dimensions in Table II. This design allowed for a sample volume of more than 50 mL,
while maintaining the required 40 mm minimum immersion depth for the probe.

Figure 28: A schematic (left) and image (right) of the 3-D printed deoxygenation vessel (part of component numbers 3, 4,
5, and 6 in Figure 25).
Table II: Dimensions of the deoxygenation vessel designed in collaboration with Lee Moore.

Deoxygenation Vessel Dimensions
Parameter
Value
Overall Height
77
Lower Half Height
40
Lower Half Inner Diameter
29
Upper Half Height
14.3
Upper Half Inner Diameter
91
Overall Volume
110
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Units
mm
mm
mm
mm
mm
cm3

3.4 Red Blood Cell Deoxygenation
3.4.1 Materials
To begin an experiment a 5 mL tube of whole blood with a pink top was obtained
from the Pathology Lab at the Cleveland Clinic Main Campus Hospital, as described in
Section 3.2.1. Again, these samples followed the Institutional Review Board (IRB)
regulations to protect the rights and welfare of the person’s whose blood was used
(Cleveland Clinic IRB #10-1064: EXEMPT. Magnetophoretic Cell Sorting and Analysis,
P.I.: Maciej Zborowski).
The modified CTV apparatus displayed in Figure 25 shows the components of the
system labeled with a number for easy identification. The flow meters are labeled by #1.
The one connected to the compressed nitrogen (N2) tank from Praxair was an Oakton™
Gildmont™ Shielded laboratory Direct-Reading Flowmeter (Fisher Scientific, Hampton,
NM), while the flow meter connected to the compressed air from the Cleveland Clinic
Main Campus house source, was a Bel-Art™ SP Scienceware™ Riteflow™ Mounted
Flowmeter (Fisher Scientific, Hampton, NM). An image of these flow meters is in Figure
29. The specifications for each meter are in Appendix A, Table’s XII and XIII, respectively.
The humidifier was labeled with #2, which is a 100 mL Pyrex bottle with a lid allowing
for gas flow in and out, contained 40 mL, or less, of water to aerate the gases to eliminate
water removal from the cells and the system to avoid the cells dying due to increased
osmotic pressure. Number 3 denoted the stir bar and plate to ensure the sample solution
within the vessel was well-mixed. The rest of the components used for these experiments
were described above in Section 3.3. How the sample solutions were prepared will be
described in Section 3.4.3.
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Figure 29: Flow meters utilized within the deoxygenation system. (Components 1 from Figure 25)

3.4.2 Methods for Calibrating the Dissolved Oxygen Probe and Meter
Before experiments could be completed, the DO probe and meter were calibrated
for 100% saturated with air and 0% saturated with air. Instructions to complete the
calibration steps were found in the manual for the DO meter (Orion star™ A213 dissolved
oxygen benchtop meter, 2015). The probe was placed through the hole in the lid of the
deoxygenation vessel and a stir bar was placed at the bottom of the vessel. NOx tubing
connected the compressed air flow to the flow meter to the humidifier and into the 90 mL
of distilled water in the deoxygenation vessel. First, the meter was turned on and the initial
reading of O2 concentration in mg/L, temperature units of °C, and percent O2 saturation
were recorded. Next, the stir bar was turned on to about 30 – 40 rpm and the compressed
air flow was turned on to the 100 mark, corresponding to about 14 mL/min. On the meter
display, the ‘f1’ key corresponded to calibration. This button was pressed, and four
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calibration options were given: ‘Air’, ‘Water’, ‘Manual’, and ‘Set Zero’. The ‘Air’ option
was selected. After, the ‘Start’ selection was pressed and calibration began. When the
percent saturated value reached 100% and stabilized, which corresponded to 160 mmHg,
8.05 mg/L at 22.5 °C, calibration was completed and logged in the meter.
For these experiments, since the percent saturated readings go below 10%
saturation, about 17 mmHg, the ‘Set Zero’ calibration was completed. This was completed
in the same fashion as the 100% calibration was done, but instead of bubbling compressed
air into the deoxygenation vessel, N2 was utilized. The N2 flow was given about an hour to
allow for the vessel to be evacuated of air. After about an hour of N2 flow, the ‘f1’
calibration button was again pressed. This time the ‘Set Zero’ option was selected, and then
‘Start’ was pressed. Once the percent saturated point was at 0.1% and stabilized, or 0.01
mg/L at 24.9 °C, calibration stopped, and the meter logged 0.1%, 1.7 mmHg, as the 0%
saturation value.
3.4.3 Methods for Deoxygenation Experiments
After obtaining a blood sample the morning of an experiment, 1 mL of whole blood
is removed and pipetted into a 15 mL Falcon tube. This sample was then centrifuged at
1,500 rpm for 5 minutes at room temperature in the Beckman Coulter Allegra™ 6R
Centrifuge. While centrifugation was being completed, 90 mL of 1PBS (phosphate buffer
solution) was added to the deoxygenation vessel. Once centrifugation is completed, the
Falcon tube is removed and the supernatant, containing platelets, white blood cells, and
residual K2EDTA, was pipetted into the biological waste. Next, 18 µL of the pelleted RBCs
were pipetted into the 90 mL of 1PBS in the deoxygenation vessel, which was estimated
to be 100,000 RBCs/mL based on the 5 billion RBCs/mL concentration of whole blood. A
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stir bar was placed in the bottom of the vessel and the lid, with the DO probe through the
center, was screwed on. The vessel was positioned on the magnetic plate to turn the stir
bar, and it was turned on. Next, the DO meter was turned on to obtain the initial reading
from the sample solution and it was recorded. The salinity of the solution was set to 8.9%
within the DO meter to account for the salt content in the 1PBS and RBCs. After the
initial reading was taken, the compressed air flow was turned on to flood the sample
solution with air to reach the 100% saturated point of the experiment, 160 mmHg.
Once the system stabilized at or above 100% saturated, the three-way Hamilton
valve, labeled A in Figure 30, was turned to allow the sample to flow into the CTV system.
Valve B was turned to allow the sample to flow through the channel to valve C and be
drawn into the glass syringe. After flushing the channel with 2 mL of sample, it was
disposed of in the waste container connected to valve C. Following the same procedure,
another milliliter was flushed through the system and disposed of. Next, 2 mL of solution
was drawn into the system for data acquisition, and valve A was turned to no longer allow
sample from the vessel to flow into the CTV system. The sample was then drawn and
infused between the two syringes attached to the channel.
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Figure 30: Deoxygenation system set up labeling the three three-way Hamilton valves.

To obtain a sample set, about 0.2 mL of sample was pushed into the channel and
given two minutes of relaxation time. Once the two minutes were over, the record button
in the Video Savant software was pressed to begin recording the frame-by-frame motion
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of the cells within the channel at a frame rate of two seconds until 60 frames was reached,
for a total of two minutes of recording time. The images were reviewed to ensure that cell
motion was uniform in velocity and direction, and then they were saved according to the
nomenclature specified by the CTV Logbook as set one. This procedure was repeated seven
times for this 2 mL sample at 100% oxygenated at room temperature, which took ~30 – 35
minutes to complete. After eight sets were completed, the protocol was repeated for the
nine remaining oxygenation levels. The specified oxygenation levels tested for a single
experiment are in Table III. Experiment #1 took about 9 hours to complete. This was the
average amount of time it took for each experiment, not including retrieving the blood
sample and preparation. Experiments 1 – 5 were completed in this fashion by starting at
100% oxygenated and decreasing to as close to 0% oxygenated as possible, typically 0.1%,
1.7 mmHg or 0.01 mg/L.
Table III: Theoretical oxygenation levels for one experiment to determine if CTV is capable to detect differences in the
magnetic mobility of RBCs.

Theoretical Oxygenation Levels for one Experiment at Room Temperature
Partial Pressure of O2,
Concentration of O2, O2 Saturation,
Elapsed Time,
mmHg
mg/L
%
mins
160
8.35
100
23
60
3.14
37.5
76
40
2.09
25
50
30
1.57
18.75
50
25
1.31
15.63
48
20
1.05
12.5
78
15
0.79
9.38
49
10
0.53
6.25
58
5
0.26
3.13
61
0.1
0.01
0.1
50
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3.4.4 Methods of Analysis
Recorded images saved through the Video Savant software were renamed to be
analyzed through ImageView, a custom image analyzing software for internal use only,
created at The Ohio State University in Dr. Jeffrey Chalmers’ Lab in the Chemical
Engineering Department. The first image from the first set being analyzed was selected,
then the processing button is pressed. Figure 31 displays the CTV parameters within the
imaging software which were adjusted to track the particle frame-by-frame. After the
position was traced, the distance the particle traveled was calculated from an average
velocity over five frames divided by the frame rate specified in the Video Savant software
(one second for the Sm verification and the glioma experiments and two seconds for the
RBC deoxygenation experiments). Therefore, on average a single cell susceptibility
measurement is repeated five times over the length of the cell trajectory (Xue, et al., 2019).
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Figure 31: Parameters changed in ImageView to ensure particles are tracked accurately. Under the ‘Set, Frame, & Timing
Information’ Section 1) ‘Setting End’ is set to the corresponding number of sets being analyzed 2) ‘Settling End’ indicates
the amount of images taken, or frames, per set 3) ‘Settling Interval (ms)’ is changed to the frame rate specified in Video
Savant in milliseconds. In the ‘Particle Identification’ Section 4) ‘Min’ indicates the minimum number of pixels a particle
will occupy at a given time 5) ‘Threshold’ brightens the images when it is reduced and dims the images when it is
increased. Section ‘Minimum Tracking Frame Numbers’ 6) ‘Settling’ represents the consecutive number of frames a
particle must be tracked to be counted in the average. ‘Image Information’ 7) ‘Width’ and ‘Height’ are also specified in
Video Savant before the images are recorded. In the ‘Calibration Information’ Section 8) the number of pixels in 10 mm
wide and 10 mm tall are specified, and for the 5 objective lens 6,519 pixels correspond to 10 mm. Lastly, the ‘Operation’
Section 9) all the boxes are checked besides the ‘Batch Proc’ box.

Within ImageView, all repeats in a set were analyzed at once, which created a .txt
file with all the information from the analysis. From there, the file is opened in Excel as a
delimited file and run through two Macros developed by two visiting students from The
Ohio State University by the names of Aaron Richardson and Masa Nakamura (Nakamura,
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et al., 2001). Over the years, the Macros have been modified to what they are today by Mr.
Lee Moore, Dr. P. Stephen Williams, and Dr. Seungjoo Haam between 2005 – 2012. The
first Macro, ‘sorter2’, organized the information into a recognizable format to be run
through the second Macro, ‘Step1’. Upon completion of running the Macros, the mean,
median, mode, standard deviation, variance, 95% confidence limits, and coefficient of
variance for the magnetic mobility and the sedimentation velocity are provided. Also, three
graphs for both the magnetic mobility and the sedimentation velocity are created with wide
binning, middle binning, and narrow binning. The raw magnetic and sedimentation
velocities are located on the second sheet labeled ‘DATA-1’ in columns B and C in the
Excel file, where the magnetic velocity is labeled ‘u_avg’ and the sedimentation velocity
is ‘v_avg’. The final version of the Excel file is then saved into the CTV results file on the
computer. This method of analysis was completed for the Sm verification study, the
deoxygenation of RBC experiments, and the glioma experiments.
3.4.5 Analysis of Sm Verification Experiments
Utilizing Equations 2.10 through 2.20 in Sections 2.6.1, an Excel file was created
to calculate Sm for the four positions identified in Section 3.1.2.
3.4.6 Analysis of RBC Deoxygenation Experiments
A MATLAB code generated by Robert Royer and modified by Dr. Maciej
Zborowski and me in 2018-2019, was then utilized to obtain more information from the
Excel files and representative graphs for the RBC deoxygenation experiments. The
MATLAB code is in Appendix B in its entirety. To begin, the ‘Run’ button in the
MATLAB ‘Live Editor’ section was pressed, and the file explorer window popped up.
Here the Excel file to be analyzed was selected, and the magnetic and sedimentation
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velocities from page ‘DATA-1’ in the Excel file were extracted. First, the data was utilized
to create a scatter plot of the sedimentation velocity versus the magnetic velocity including
marginal histograms of the count of particles at specific locations. The points graphed on
the scatter plots were completed utilizing a color-coding system, indicating where the most
particles fell on the plot and the color bar with the high volume (yellow) and low volume
(blue) color scheme located to the right of the sedimentation velocity histogram. Next, kmean clustering was utilized to partition the sample group into two different clusters with
similar data points and discover underlying patterns within the dataset (Garbade, 2018).
Once the clusters were identified, they were plotted on the sedimentation versus
magnetic velocity scatter plot with cluster 1, identified by red points and cluster 2,
identified by blue points, and their center of masses were labeled by black dots in the
groups. Each group was graphed separately in the same manner as the whole dataset was
first graphed in the color-coded scatter plot with histograms. The magnetic histograms were
then fitted to a gaussian model to determine the peak (a1), the mode (b1), and the standard
deviation (c1) for each cluster. The gaussian fit equation utilized is found in Equation 3.1
below. The last graph generated in the MATLAB code was a combination of the original
magnetic histogram from the whole dataset in a blue stair-type graph with a black line
corresponding to the sum of cluster 1 and 2’s gaussian curves, the light purple line graphing
subset 1’s gaussian, and the red line plotting subset 2’s gaussian. To compare the
functionality of the gaussian curve fitting code in MATLAB, a Welch’s t-test for unequal
variances and unequal sample sizes was coded. This statistical analysis is an adaptation of
the Student’s t-test; however, it is more reliable for samples with unequal variances and/or
unequal sample sizes, which is present in the experiments being analyzed.
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𝑓(𝑥) = 𝑎1 𝑒

−(

𝑥−𝑏1 2
)
𝑐1

(3.1)

The last part of the MATLAB code compiles key points from data analysis into an
Excel file. Original magnetic and sedimentation velocities were put into the sheet labeled
‘All’. Points within cluster 2 were put into a sheet labeled ‘A’ for subset A, while points in
cluster 1 were located in the sheet labeled ‘B’. The center of masses for each cluster and
their standard deviation were in sheet ‘CENTS’. Gaussian coefficients for subset A were
put in sheet ‘GaussA’ and subset B were put in sheet ‘GaussB’. Welch’s t-test results were
stored in sheet ‘Ttest’ with a p-value equal to 0.95. This included the alpha-value, the
number of points, mean, and standard deviation of each cluster, along with the degrees of
freedom denoted as v, the t statistic as tval, and the 1-tail t-distribution denoted as ‘tail1’
and the 2-tail t-distribution denoted as ‘tail2’. Equation’s 3.2 and 3.5 demonstrate how the
degrees of freedom and the t statistic were calculated for the Welch’s t-test, respectively.
The sample variance is denoted as s, sample size is N, and 𝑋̅ is the sample mean. The last
sheet in the Excel file generated from the MATLAB code provides the upper and lower
confidence limits of both subsets for the t-test and the gaussian curve fitting.
2

𝑠2 𝑠2
( 1 + 2)
𝑁
𝑁2
𝑣 = 41
𝑠1
𝑠24
+
𝑁12 𝑣1 𝑁22 𝑣2

(3.2)

𝑣1 = 𝑁1 − 1

(3.3)

𝑣2 = 𝑁2 − 1

(3.4)
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tval =

̅̅̅1 − 𝑋
̅̅̅2
𝑋
√

𝑠12 𝑠22
𝑁1 + 𝑁2

(3.5)

Reduction of the data gathered from the MATLAB code was the last step when
analyzing the results. The gaussian coefficients of subset A and B at each oxygenation level
for one experiment were compared, where gaussian 1 was defined as the magnetic velocity
closest to zero and gaussian 2 was the one farthest from zero. This varies between cluster
1 and 2 for each oxygenation level. The b-values, or the mode of the gaussian, were then
plotted versus the oxygenation level they were measured at, with error bars corresponding
to the c-values, standard deviation of the mode. Next, the b-values were normalized from
0 to 1 and graphed versus the oxygenation state with a best fit line consistent with the Hill
equation describing the cooperative binding scheme of oxygen to hemoglobin. In Equation
3.6, Y is the normalized b-value, which is described further below.
𝑌≡

𝑦0 − 𝑦
𝑦0

(3.6)

From the stated hypothesis, Y follows the Hill equation specified in Equation 3.7 of the
order n and constant parameter k’, where variable x is the experimental pO2 value

𝑌=

𝑥𝑛
𝑘′ + 𝑥𝑛

(3.7)

Equation 3.7 is algebraically manipulated to convert it to have a linear relationship between
some closed-form functions of Y and x in Equations 3.8 through 3.10.
𝑘′𝑌 + 𝑥𝑛 𝑌 = 𝑥𝑛
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(3.8)

𝑥𝑛 =

𝑘′𝑌
1−𝑌

𝑛log(𝑥) = log(𝑘 ′ ) + log (

(3.9)

𝑌
)
1−𝑌

(3.10)

Equation 3.8 can be further simplified to Equation 3.9 by introducing variable Z and
redefining the constant k’ in Equation 3.10.
𝑍≡

𝑌
1−𝑌

𝑘 ≡ − log(𝑘 ′ )

(3.11)

(3.12)

The desired result, presented in Equation 3.13, is the linear relationship between the
function of the experimentally measured b-value, log(Z), and the function of the
independently varied experimental value of pO2, log(x).
log(𝑍) = nlog(𝑥) + 𝑘

(3.13)

For these equations, Y is the fractional saturation of oxygen bound to the hemoglobin, n is
the Hill coefficient also known as the slope of the regression line of the linearized Hill
equation, which corresponds to Z in Equation 3.11, and k is 10 raised to the negative value
of the y-intercept from the regression line of the linearized Hill equation. For Equation 3.6,
y0 is the maximum b-value in an experiment (one experiment corresponds to sets at 160
mmHg to 0 mmHg) minus the minimum b-value and y is the original b-value minus the
minimum b-value (Weiss, 1997). The Hill parameters n and k were determined by the usual
method of least-square fitting of a straight line to the experimental data of log(Z) on log(x),
whose significance was calculated by the linear regression analysis. For normal blood,
parameter n ranges from 1.5 – 2.5 for pO2<30 mmHg and reaches the saturation value of
2.7 at about 30 mmHg (Dash, et al., 2016). From here, conclusions were drawn to
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determine if the hypothesis was correct about CTV being able to differentiate RBC
subfractions differing in oxygenation levels.
3.5 Glioma Progenitor Cell Experiments
3.5.1 Materials
The glioma cell cultures were provided by Soumya Turaga, a graduate student in
Dr. Justin Lathia’s lab at the Cleveland Clinic, LRI. Originally, three different cultures
were tested, 3T3 (control), GL26, and GL261, which were all murine models which were
cultured for more than 20 passages. The 3T3 control were simply neural stem cells, while
GL26 and GL261 were forms of glioblastoma/ependymoblastoma (Oh, et al., 2014).
Preclinical testing of immunotherapeutic approaches for GBM have been most extensively
completed on the GL261 model (Oh, et al., 2014). The GL261 and GL26 models are
similar, but the GL26 tumors present greater necrosis and vascularity as well as being
hemorrhagic (Oh, et al., 2014). All these cells were cultured in RPMI (Roswell Park
Memorial Institute) 1640 media (ThermoFisher Scientific, Waltham, MA) supplemented
with 10% fetal bovine serum and 1% penicillin/streptomycin, which was also provided by
Soumya. The last material supplied by Soumya in Dr. Lathia’s lab was 4% PFA
(paraformaldehyde, made by Soumya Turaga at Cleveland Clinic, LRI) fixative to secure
the cells onto the Mylar slide after MDM was completed, as well as after a cytosmear was
generated within the cytospin.
The MSB-Auto described in Section 2.3 and the CTV components defined in
Section 3.1.1 were applied to the glioma experiments to validate the MATLAB analysis.
Shandon Cytospin 3 (Thermo Fisher Scientific, San Francisco, California), displayed in
Figure 32, was used to create cytosmears of the glioma cells. Specifications for the
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instrument are in Appendix A, Table XVII (Cytospin: Cell Preparation System Operator
Guide, 1997). Components needed for the cytospin were the stainless steel Cytoclip™ slide
clip, a microscope slide with a circle where the sample is released onto the slide, and a
disposable Cytofunnel® with a sample chamber and filter card (Cytospin: Cell Preparation
System Operator Guide, 1997). The method of how the sample was prepared and put
together with the Cytoclip™, microscope slide, and Cytofunnel® will be described in
Section 3.5.2.

Figure 32: Shandon Cytospin 3 (Thermo Fisher Scientific, San Francisco, CA) used to create cytosmears of glioma
cultures (Cytospin: Cell Preparation System Operator Guide, 1997).

The MDM magnet described in Section 2.6.2 was also used to determine if
magnetic separation is possible between CSCs and other brain cells. The magnet assembly
was made up of three sizes of neodymium-iron-boron 42 MG Oe energy blocks (Applied
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Magnet, Plano, TX). The steel yokes and aluminum supports were put together at the
Cleveland Clinic, LRI. The two interpolar gaps had a width of 1.6 mm each and the
maximum magnetic field intensity between these gaps in the 0y direction was measured to
be By = 0.475 T. Five flow channels, each 6.3 mm wide and 15 mm long, were cutout into
a 0.25 mm thick rubber spacer. The rubber spacer was squeezed between a 0.13 mm thick,
poly-l-lysine coated Mylar sheet, acting as a microscopy substrate slide, and a
polycarbonate manifold. The orientation and components in the assembly are displayed in
Figure 33.

Figure 33: Magnet assembly (Buck, et al., 2014).

To facilitate sample flow through the channel, FEP, 0.508 mm inner diameter 
1.59 mm outer diameter tubing (Zeus Industrial Products, Orangeburg, SC) was threaded
through the manifold on both the top and bottom. While syringes were connected to the
tubing leaving the top of the manifold, they were attached to the kd Scientific Legato 210P
multi-syringe pump, displayed in Figure 34 and specifications in Appendix A, Table XVIII.
Within the pump, flow rates could be specified and programed, allowing for controlled and
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precise fluid flow in the channels. The flow rates utilized for the glioma experiments will
be described in Section 3.5.2.

Figure 34: Legato 210P multi-syringe pump adaptor from kd Scientific (Hollison, MA) utilized in MDM (Legato
210/210P Syringe Pump, 2016).

3.5.2 Methods
First, the RPMI media utilized to culture the cells was tested with the MSB-Auto,
applying the same procedure described in Section 3.1.3, to ensure the media did not present
any magnetic properties which could be absorbed by the cells and inadvertently make them
magnetic. Also, distilled water and MilliQ water were both measured to verify the magnetic
susceptibility of the RPMI media was not statistically significantly different from water.
The statistical analysis is in Section 4.4.
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The morning of an experiment, a sample was received from Soumya containing
about 1,000,000 cells/mL of solution. About 10,000 cells were needed for a cytosmear,
100,000 cells for each of the five MDM channels, 50,000 cells for Countess, and 1,000,000
cells/mL for CTV. The 50,000 cells for Countess were removed first to give to the
Cleveland Clinic LRI FlowCore to determine the size and viability of the cells. From
experiment to experiment, the amount of sample removed from the original 1,000,000
cells/mL solution for each test varied due to the number of cells Soumya was able to
provide. Next, five 1.5 mL sample vials were prepared for MDM. The 20,000 cells for two
cytosmears were then pipetted into a 1.5 mL sample vial, which also contained excess
RPMI media. The remaining of the cells were utilized for CTV.
MDM was the test which took the most amount of time to complete. Therefore, this
was the first to start running. To begin, the Mylar slide was cut to size to cover the five
channels, and the bottom right corner was cut diagonally, as seen in Figure 35, to know
which channel was located where on the slide. Next, ten pieces of tubing was cut about 10
inches long. The tubing was then pulled at one end with plyers to thin it out to be able to
thread it into the manifold. Once all ten pieces of tubing were in the manifold, the excess
tubing on the inside of the manifold was cut off to provide a smooth surface for the rubber
spacer and Mylar slide to sit. After the rubber spacer and Mylar slides were in place on the
manifold, all three pieces were sandwiched together with the magnet assembly. The order
was the magnet assembly, Mylar slide, rubber spacer, then the manifold threaded on four
bolts sticking out of the outer edges of the magnet assembly. Next, the platen was placed
next to the manifold on the bolts and screws were tightened to create an airtight seal within
the channels and to ensure no sample would leak out once fluid flow began.
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Figure 35: Schematic of a Mylar slide, 25 mm  75 mm, used within MDM as a microscope slide, cut on the bottom right
corner to determine the locations of the channels.

When the magnet was assembled, the tubing at the top of the manifold needed to
be connected to the syringes using a male chromatography fittings (¼-28  1/16”) and ¼28 male-to-female Luer adaptors from Upchurch Scientific. The adaptors were a
modification from the original Hamilton valves utilized for the process, due to
complications of not every channel drawing up sample when the pump was turned on. Once
the syringes were connected to the tubing, they were secured to the pump. About 1 mL of
MDM carrier solution was placed in a 1.5 mL sample vial and placed at the bottom of each
channel with the tubing placed inside the solution. On the pump, program Nina_C was
selected to first determine which channels were withdrawing and infusing sample properly,
and to coat the inside surfaces of the tubing and Mylar slide. The different pump programs
utilized for the glioma experiments are listed in Table IV. About 10 minutes later, the
carrier solution was withdrawn into the syringe and infused back into the sample vial, and
the vials were switched out for the glioma samples. Program Nina_U was selected.
Table IV: Pump programs implemented by Nina Smith.

Program Name
Nina_C
Nina_U
Nina_D
Nina_M_U
Nina_M_D

MDM Pump Programs
Withdraw/Infuse
Rate, mL/min
Withdraw
0.2
Infuse
0.2
Withdraw
0.026
Infuse
0.03
Withdraw
0.13
Infuse
0.13
72

Volume, mL
0.8
0.7
0.7
0.6
0.6
0.6

Time, min
4.0
3.5
26.92
20.0
4.62
4.62

While waiting for MDM to finish, two cytosmears were created, one for PFA, the
fluorescent fixative, and one for HEMA fixative. First, the 20,000 cells were split into two
1.5 mL sample vials with RPMI media. After the samples were prepared, the Cytoclip™,
microscope slide, and the disposable Cytofunnel® were put together as displayed in Figure
36. Two of these combinations were prepared, with the microscope slide indicating which
sample would be fixed with HEMA solution and which would be fixed with PFA. Next,
0.3 mL of the sample solutions were pipetted into the disposable Cytofunnel®. Both
Cytoclip’s™ were taken over to the Cytospin 3 and placed on opposite sides of the
centrifuge to keep the system at equilibrium. The machine was then turned on and program
number 2 was selected, which was preprogramed.

Figure 36: Schematic of how the Cytoclip™ slide clip, the microscope slide, and the disposable Cytofunnel® are put
together to be placed into the cytospin (Cytospin: Cell Preparation System Operator Guide, 1997).

After 5 minutes, the cytospin stopped and the samples were removed. The
disposable Cytofunnel® was removed and thrown away in the biological waste bin, while
the Cytoclip’s™ were placed back into the Cytospin 3, and the machine turned off. The
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slide marked HEMA fixative was first dunked into the light blue HEMA solution five
times, then five times in the red HEMA solution, and lastly five times in the purple HEMA
solution. The slide was then left in the open to dry. Next, about 50 µL of PFA was dropped
on the cells within the circle on the slide marked PFA. The PFA was left on the cells for
15 minutes, and then it was washed off by dunking the slide in 1PBS five times. The slide
was then placed inside the refrigerator at 4°C until Soumya was able to fluorescently stain
the cells. Once the HEMA slide was dry, a cover slide was placed over top of the slide to
be taken to ImageCore to be imaged.
After the cytosmears were finished and while the MDM experiment was still
running, the sample for CTV was prepared. The CTV procedure described for the Sm
verification experiments was mimicked. A sample concentration of about ~100,000
cells/mL was drawn up into a 5 mL syringe. The syringe was attached to the Luer adaptors
connected to the Hamilton valve on one end of the CTV channel, while an empty syringe
was attached to the Hamilton valve on the opposite side of the channel. Then the valves
were turned to allow for about 0.2 mL of the sample to be pushed through the channel to
the empty syringe over a time span of about 3 seconds. Next, the valves were closed to stop
fluid flow, and the cells were given about 30 seconds of relaxation time before the motion
of the cells was recorded. After, the record button in the Video Savant software was pressed
to begin recording for 60 frames at a frame rate of 1 second, totaling a minute of acquisition
time. The images were reviewed once the recording was complete to ensure the cells moved
in a uniform velocity and direction. The images were saved according to the nomenclature
specified by the CTV logbook as set one. This process was repeated 7 times, for a total of
8 sets over a time span of 20 – 25 minutes. The methods of analysis for the glioma
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experiments imitated those for the deoxygenation experiment described in Section 3.4.4
and 3.4.6. The part not completed, was for the analysis of the gaussians with the Welch ttest through the data reduction with the Hill equation.
Once the MDM program Nina_U was completed, program Nina_D was run. After
it was done, the sample vials at the bottom of the tubing was switched out for vials
containing 1 mL of PFA. PFA was drawn into the syringes at the top utilizing program
Nina_M_U, and the PFA was left sitting in the channels for 15 minutes to allow for the
cells to be fixed to the Mylar slide. When the 15 minutes was up, program Nina_M_D was
run, so all the PFA was removed from the tubing and channels back into the sample vials.
Once this was completed, the system was carefully disassembled. The syringes were
removed from the pump holding location and the tubing connected to the top of the
manifold was detached. The tubing at the bottom of the manifold was then disconnected
and taken out of the sample vial. The sample vial was then closed to ensure none of the
sample would spill. The tubing, syringes, and the samples were then discarded in the
biological waste. Next, the magnet assembly was taken apart first by removing the screws
and the platen. The Mylar slide was peeled off the rubber spacer and placed off to the side
to confirm it was not contaminated. All the adaptors, rubber spacer, and the manifold were
cleaned using 70% alcohol and bleach. Lastly, the Mylar slide was taped to a glass slide
and stored in the refrigerator at 4°C until Soumya was able to stain the cells.
3.6 Exploration of the Effects of a Temperature Gradient on the Separation of Red
Blood Cells
To begin, theoretical calculations were completed for water at 0°C as the cold wall
and 40°C for the hot wall, to determine if applying a temperature gradient to the MDM
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system would facilitate separation of the viable RBCs. The local water velocity profile in
a thin channel bounded by a ‘cold wall’ (0°C) and a ‘hot wall’ (40°C), due to temperaturerelated changes in the local water density and in the absence of imposed volumetric flow,
were calculated from Equation 2.35 (Giddings, 1991). The numerical values of water
density, ρ, the water thermal expansion coefficient, γ, the width of the channel, w, the
temperatures of the ‘hot wall’ and ‘cold wall’, °C, and the water viscosity, η, are listed in
Table V. The local water velocity, v(y), was calculated as a function of y, which was the
distance from the ‘cold wall’. The maximum value of the local water velocity induced by
the temperature difference between the ‘hot’ and ‘cold’ walls was compared to the known
RBC sedimentation velocity in order to determine if it was large enough to affect the RBC
sedimentation by entrainment in the falling or rising layer of water in the channel. The
results are presented as a plot of v(y) on y in Section 4.5.
Table V: Constants utilized to create Figure 74 Giddings velocity profile.

Giddings Velocity Profile Parameters
Parameter
Value
Width of Channel
0.25
Density
998
Thermal Expansion Coefficient
2.0710-4
Dynamic Viscosity
1.0010-3
Cold Wall Temperature
0
Hot Wall Temperature
40

Units
mm
kg/m3
1/K
Pas (Ns/m2)
°C
°C

Once calculations were completed, computational modeling was begun through a
cross-platform finite element analysis solver and multiphysics simulation software called
COMSOL Multiphysics 5.3. Before modeling could be completed with the MDM
assembly, tutorials for different types of fluid flow were completed. One example was
erosion within a pipe elbow due to particle contamination. It demonstrated how to setup
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the single-phase turbulent fluid flow physics within COMSOL, which were needed to
complete the simulations. From there, the geometry of the pipe was drawn, which is similar
to how geometries are drawn in SolidWorks. Next, the physics were defined further for the
model, which was where the turbulent flow entering and exiting the pipe and the inlet
velocity of the fluid were specified. Then the fluid material was defined as water, and the
pipe mesh was applied, which distributes the stresses of the flow through the pipe for a
more realistic representation of the fluid flow. After, a study was computed to determine
the fluid velocity streamlines and the points within the pipe which experience the most
pressure. Due to the limitations of the version of COMSOL accessible, the contamination
particles were not able to be added to the simulation to finish the tutorial.
Once the tutorial was completed, modeling for the temperature gradient began
utilizing the same physics from the pipe tutorial, single-phase turbulent fluid flow. First,
the MDM magnet assembly, originally designed in SolidWorks and provided by Lee R.
Moore, was imported into the COMSOL software utilizing an .STL file, allowing for a
more accurate theoretical model. Initially, meshing was attempted with the whole magnet
assembly, but this caused the program to take a few hours to complete. Therefore, the
geometry was cut from the whole assembly to just one channel within the assembly. Figure
37 displays the whole assembly and just one channel of the assembly. Next, the fluid was
specified as water and the inlet and outlets were specified. Last, the velocity and pressure
profiles were generated for water flowing through the single channel.
Multiple attempts were completed to ensure the fluid was flowing through the
tubing of the manifold into the channels. The second attempt was done by extruding an
inlet and outlet from the tubing, which is present in the single channel assembly of Figure
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37. Attempt number three, tubing was drawn through the manifold holes to the channel
itself. The last attempt, the tubing walls were selected as boundaries to facilitate fluid flow.
These simulation results will be further discussed in Chapter IV – Results and Discussion.

Figure 37: Above: Full MDM magnet assembly. Below: One channel of the assembly.

78

CHAPTER IV
RESULTS AND DISCUSSION
4.1 Sm Verification Results
The objective of this experiment was to validate the Sm value of the Mk V magnet
assembly to ensure the particles are exposed to a uniform magnetic field when carrying out
experiments on CTV. To begin calculations, Equation 2.20 in Section 2.6.1 was utilized to
convert the mean magnetophoretic mobility (mm3/T-A-s) to the mean magnetic velocity
(mm/s), utilizing the current Sm value of 365 T-A/mm2 (Xue, et al., 2019). Next, Δχ of the
solution was calculated from Equation 2.12, with the assumption that MDM buffer has the
same magnetic susceptibility as water, and the solution was measured by the MSB-Auto,
described in Section 3.1.3. The theoretical volumetric, magnetic susceptibility of water is
-7.1910-7 (CGS), which corresponds to -9.03510-6 (SI) (Zborowski, et al., 2003). The
50/50 Magnevist and MDM buffer solution was measured to have a magnetic susceptibility
of 6.7710-5, in SI units, but it was calculated to be 7.5810-5 (SI), which is a 10.68%
difference between the two values. Then, these values were used to evaluate Equation 2.15
to obtain an Sm value, where the particle diameter and viscosity of the solution were kept
constant for the calculations. These results are presented in Figure 38.
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Sm Verification Results
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Figure 38: Results to determine the FOV location and the value of Sm.

In Figure 38, the highest Sm value is located at 4.5 mm away from the edge of the
magnet. Figure 11, of the theoretical model for the Mk V magnet, also indicates around 4.5
mm away from the edge of the magnet, the Sm value is the highest. However, the
experimental values for Sm are much higher than the original 365 T-A/mm2 (theoretical)
795 ± 212 T-A/mm2 (Δχ from literature) and 880 ± 235 T-A/mm2 (Δχ measured by MSBAuto). The potential sources of irregularity are discussed in Section 4.6.
4.2 Spectrophotometry Results
Specific aim number two was to determine the concentration levels of metHb and
oxyHb within samples through spectrophotometry. As described in Section 3.2.2, the
spectrum of two samples were measured over a wavelength range of 500 – 700 nm. The
results are displayed in Figure 39 below. Around wavelength 577 nm, oxyHb rises steeply
into a second peak. At wavelength 630 nm, a small peak is seen in the metHb curve. Also,
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around 560 nm, both the oxyHb and metHb curves dip into a trough, indicating the presence
of hemicrhomes, or unstable hemoglobin, within the samples.

Spectra for metHb and oxyHb
1.8
1.6

Absorbance

1.4
1.2
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Figure 39: Results from running spectrophotometry on the oxyHb and metHb samples over a range of 500 - 700 nm.

Following the experiments, post-processing calculations were completed to determine the
concentration of oxyHb, metHb, and hemicrhomes in the samples utilizing Equations 2.32
through 2.34. The results are displayed in Table VI and will be discussed in Section 4.7.
Due to the high error associated with pipetting small amounts of the sample’s multiple
times and the accuracy of the spectrophotometer absorbance readings, the values of the
oxyHb concentration in the metHb sample and hemichrome concentration in the oxyHb
sample are below zero, however they are within the standard deviation. The suitable
concentration for oxyHb and metHb for spectrophotometry measurements are 40 µM per
heme group (Winterbourn, 1990).
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Table VI: Concentrations calculated from Equations 2.32-2.34 to obtain the concentration of oxyHb, metHb, and
hemichrome within the samples analyzed by spectrophotometry.

Type
metHb
oxyHb

Concentration Results Calculated with Winterbourn's Equations
A560 A577 A630
[oxyHb], µM
[metHb], µM
[hemi], µM
0.51
0.52
0.43
-0.36 ± 0.45
119.13 ± 0.45
0.422 ± 0.45
0.99
1.67
0.08
107.70 ± 1.03
16.42 ± 1.03
-1.0 ± 1.03

4.3 Deoxygenation of Red Blood Cell Results
The purpose of the deoxygenation of RBC experiments was to determine if CTV is
capable of distinguishing different RBC subfractions when the levels of oxygenation were
varied. Analysis began by running the Excel Macros described in Section 3.4.4 to obtain
the magnetic mobility and sedimentation velocity results using CTV. The magnetic
mobility versus the pO2 for Experiments 1 and 2 are shown in Figures 40 and 41,
respectively. These graphs demonstrate that as the pO2 level decreases, the magnetic
mobility of the RBCs increases.

Magnetic Mobility for Experiment #1
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Figure 40: Magnetic mobility versus the pO2 level for Experiment #1.
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Magnetic Mobility for Experiment #2
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Figure 41: Magnetic mobility versus the pO2 level for Experiment #2.

These results were then run through the MATLAB code, which generated a variety of
graphs. Also, the original magnetic mobility and sedimentation velocity data, the original
data split into cluster’s 1 and 2, the Gaussian coefficients for the separate clusters, and
Welch’s t-test information was printed to a different Excel file to be further analyzed
against the Hill equation.
4.3.1 Results Generated through the MATLAB Code for Experiment #1
The MATLAB code generated nine plots when analyzing the data for one
oxygenation level. For the purpose of this study, only three were analyzed: 1 – the overall
color coded dataset with the magnetic and sedimentation velocity histograms, the left graph
in Figure 42, 2 – the original data split into two clusters based on the k-means clustering
method, the right graph in Figure 42, and 3 – the Gaussians of the two clusters (red and
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light purple curves) overlaid on the original magnetic velocity histogram (light blue stairstype), and the sum of the cluster Gaussians (black), the top graph in Figure 43. As
mentioned before, the red curve in the top graph in Figure 43 corresponds to cluster 2, and
the light purple curve correlates to cluster 1. These three figures are the results of the pO2
level at 160 mmHg for Experiment #1. The bottom graph in Figure 43, was created by Dr.
Maciej Zborowski through Maple, is the theoretical behavior of an RBC when it is fully
oxygenated.

Figure 42: MATLAB graphs generated for the 160-mmHg oxygenation level in Experiment #1. On the left is the whole
dataset with histograms and to the right are the two clusters generated by the k-mean clustering method.
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Figure 43: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 160 mmHg. Below: Graph created in
Maple for RBC behavior at 160 mmHg predicted from the Adair equation.

85

When comparing the taller gaussian peak to the left (red curve) in the top graph of
Figure 43 and the gaussian peak in the bottom graph in Figure 43, they are both slightly to
the left of zero. As the oxygenation level decreased during Experiment #1, the RBC’s
magnetic velocity increases, as demonstrated in Figures 42 – 61. Again, at each
oxygenation level, the experimental motion of an RBC (graphs from MATLAB) were
compared to the theoretical motion predicted from Adair’s Equation 2.25 (graphs created
in Maple).

Figure 44: MATLAB graphs generated for the 60-mmHg oxygenation level in Experiment #1. On the left is the whole
dataset with histograms and to the right are the two clusters generated by the k-mean clustering method.
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Figure 45: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 60 mmHg. Below: Graph created in
Maple for RBC behavior at 60 mmHg predicted from Adair equation.
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Figure 46: MATLAB graphs generated for the 40-mmHg oxygenation level in Experiment #1. On the top is the whole
dataset with histograms and to the bottom are the two clusters generated by the k-mean clustering method.
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Figure 47: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 40 mmHg. Below: Graph created in
Maple for RBC behavior at 40 mmHg predicted from Adair equation.
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Figure 48: MATLAB graphs generated for the 30-mmHg oxygenation level in Experiment #1. On the top is the whole
dataset with histograms and to the bottom are the two clusters generated by the k-mean clustering method.
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Figure 49: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 30 mmHg. Below: Graph created in
Maple for RBC behavior at 30 mmHg predicted from Adair equation.
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Figure 50: MATLAB graphs generated for the 25-mmHg oxygenation level in Experiment #1. On the top is the whole
dataset with histograms and to the bottom are the two clusters generated by the k-mean clustering method.
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Figure 51: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 25 mmHg. Below: Graph created in
Maple for RBC behavior at 25 mmHg predicted from Adair equation.
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Figure 52: MATLAB graphs generated for the 20-mmHg oxygenation level in Experiment #1. On the top is the whole
dataset with histograms and to the bottom are the two clusters generated by the k-mean clustering method.
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Figure 53: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 20 mmHg. Below: Graph created in
Maple for RBC behavior at 20 mmHg predicted from Adair equation.
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Figure 54: MATLAB graphs generated for the 15-mmHg oxygenation level in Experiment #1. On the top is the whole
dataset with histograms and to the bottom are the two clusters generated by the k-mean clustering method.
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Figure 55: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 15 mmHg. Below: Graph created in
Maple for RBC behavior at 15 mmHg predicted from Adair equation.
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Figure 56: MATLAB graphs generated for the 10-mmHg oxygenation level in Experiment #1. On the top is the whole
dataset with histograms and to the bottom are the two clusters generated by the k-mean clustering method.
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Figure 57: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 10 mmHg. Below: Graph created in
Maple for RBC behavior at 10 mmHg predicted from Adair equation.
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Figure 58: MATLAB graphs generated for the 5-mmHg oxygenation level in Experiment #1. On the top is the whole
dataset with histograms and to the bottom are the two clusters generated by the k-mean clustering method.
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Figure 59: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 5 mmHg. Below: Graph created in Maple
for RBC behavior at 5 mmHg predicted from Adair equation.
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Figure 60: MATLAB graphs generated for 0.1% O2 saturation level in Experiment #1. On the top is the whole dataset
with histograms and to the bottom are the two clusters generated by the k-mean clustering method.
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Figure 61: Above: Gaussian curves for the k-mean clusters for Experiment #1 at 0.1% O2 saturation level. Below: Graph
created in Maple for RBC behavior at 0.1% O2 saturation level predicted from Adair equation.
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Comparing the top graphs in Figure 43 (160 mmHg) and Figure 61 (about 1.7
mmHg, or 0.1% saturation) confirms that at lower oxygenation levels (high spin
hemoglobin molecules, unpaired electrons) the magnetic velocity of an RBC is greater than
at higher oxygenation levels (low spin hemoglobin molecules, covalently bonded to O2).
When relating the experimental graphs to the theoretical graphs for 60-30 mmHg, the peaks
of the gaussians move comparably well with each other. However, for 25 mmHg and lower,
the experimental graphs indicate the existence of fewer magnetic cells than the theoretical
graphs display. Also, Figure 61 demonstrates the possible presence of varying oxygenated
subfractions of RBCs due to the widespread distribution of the data. The graphs for
Experiment #2 are below in Figures 62 – 71. Comparing the gaussian curves from
Experiment #1 to the gaussian curves from Experiment #2, there is a clear pattern seen in
the magnetic velocities while decreasing the pO2 between these two experiments. Due to
limitations of the MATLAB code, analysis of Experiments 3 – 5 were not available at this
time.
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Figure 62: MATLAB graphs generated for 160 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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Figure 63: MATLAB graphs generated for 60 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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Figure 64: MATLAB graphs generated for 40 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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Figure 65 MATLAB graphs generated for 30 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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Figure 66 MATLAB graphs generated for 25 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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Figure 67: MATLAB graphs generated for 20 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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Figure 68: MATLAB graphs generated for 15 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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Figure 69: MATLAB graphs generated for 10 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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Figure 70: MATLAB graphs generated for 5 mmHg oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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Figure 71: MATLAB graphs generated for 0.1% O2 oxygenation level in Experiment #2. Top Left: Whole dataset with
histograms. Top Right: Two clusters generated by the k-mean clustering method. Below: Gaussian curves for the k-mean
clusters.
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4.3.2 Gaussian Fit Results Compared to the Hill Equation
Once each oxygenation level was evaluated through MATLAB, the Gaussian
coefficients generated for the two clusters, specified by the k-mean clustering method, were
utilized to create six graphs per experiment. The first graph, Figure 72, is the magnetic
velocity mode values in mm/s (b gaussian coefficients) versus the partial pressure of O2 for
Gaussian 1 for Experiment #1, with error bars representing the standard deviation. Figure
73 is the same plot; however, it represents the values for Gaussian 2. As mentioned before,
Gaussian 1 is comprised of the clusters with b-values closest to zero, which varied in cluster
from oxygenation level to oxygenation level. This convention for Gaussian 1 and 2 is
represented in Figures 72 and 73. Gaussian 1 does not have a b-value higher than about
1.5x10-3 mm/s, whereas Gaussian 2’s highest b-value was around 3.5x10-3 mm/s. The same
graphs for Experiment #2 are in Figures 74 and 75.

Gauss 1 Mode of the Magnetophoretic Velocity for
Experiment #1
0

20

Partial Pressure of O2, mmHg
40
60
80
100
120

140

160

Experimental b-values, mm/s

0.004
0.003
Experimental
Data

0.002
0.001
0
-0.001
-0.002
Figure 72: Gaussian 1 magnetophoretic velocity mode for Experiment #1.
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Gauss 2 Mode of the Magnetophoretic Velocity for
Experiment #1
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Figure 73: Gaussian 2 magnetophoretic velocity mode for Experiment #1.
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Figure 74: Gaussian 1 magnetophoretic velocity mode for Experiment #2.
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Gauss 2 Mode of the Magnetophoretic Velocity for
Experiment #2
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Figure 75: Gaussian 2 magnetophoretic velocity mode for Experiment #2.

The next graph produced with the MATLAB gaussian coefficients was the
normalized b-values versus partial pressure of O2, along with the Hill equation curve fitted
for the experimental data. The fitted curve was generated through the ‘Regression’ option
within the ‘Data Analysis’ section of Excel to obtain the slope (n) and intercept (k). Also,
a linear regression of the log(Z) values versus the log(x) values calculated from Equations
3.10 and 3.13 were made through the ‘Regression’ option. Figures 76 and 77 represent the
data in Gauss 1 for Experiment #1, while Figures 78 and 79 are the same graphs, but for
the data within Gauss 2 in Experiment #1. The corresponding graphs for Experiment #2
are Figures 80 – 83.
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Figure 76: Hill curve for the Gauss 1 data for Experiment #1. Normalized experimental b-values graphed with a fitted Hill
curve generated by the regression of the experimental values
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Figure 77: Linear regression of Gauss 1 data for Experiment #1. Regression was completed for the normalized log(Z) and
log(x) experimental values.
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Hill Fit to Gauss 2 Data for Experiment #1
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Figure 78: Hill curve for the Gauss 2 data for Experiment #1. Normalized experimental b-values graphed with a fitted Hill
curve generated by the regression of the experimental values.
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Figure 79: Linear regression of Gauss 2 data for Experiment #1. Regression was completed for the normalized log(Z) and
log(x) experimental values.
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Figure 80: Hill curve for the Gauss 1 data for Experiment #2. Normalized experimental b-values graphed with a fitted Hill
curve generated by the regression of the experimental values
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Figure 81: Linear regression of Gauss 1 data for Experiment #2. Regression was completed for the normalized log(Z) and
log(x) experimental values.

120

Normalized b-values

Hill Fit to Gauss 2 Data for Experiment #2
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0

Hill Fit Curve

0

20

40
60
80
100 120
Partial Pressure of O2, mmHg

140

160

Figure 82: Hill curve for the Gauss 2 data for Experiment #2. Normalized experimental b-values graphed with a fitted Hill
curve generated by the regression of the experimental values.
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Figure 83: Linear regression of Gauss 2 data for Experiment #2. Regression was completed for the normalized log(Z) and
log(x) experimental values.
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The specific values from these graphs, which are important in determining whether
the Hill equation is a representative model for the deoxygenation of RBC experiments, are
the slope (n) and intercepts (k) for the linear regression graphs, Figures 77, 79, 81, and 83.
These values for Experiments 1 and 2 are summarized in Table VII below. Compared to
common practice of setting n = 2.7 in literature, the values obtained through experiments,
found in Table VII, were on average 65.53% lower.
Table VII: Regression line information for both Gaussians in Experiments 1 and 2.

Regression Line Slope and Intercept Information
Experiment Gaussian
Slope, n
Intercept, k Slope P Value Intercept P Value
1
1.77 ± 0.35 -1.76 ± 0.45
9.210-4
4.610-3
1
2
0.91 ± 0.55 -0.79 ± 0.76
0.14
0.33
-3
1
1.53 ± 0.36 -1.8 ± 0.47
2.810
5.010-3
2
2
1.36 ± 0.41 -1.71 ± 0.58
0.01
0.02

4.4 Results for Glioma Experiments
The specific aim for the glioma experiments was to determine the magnetic
properties of the GL261 cell cultures provided by Dr. Justin Lathia’s lab at the Cleveland
Clinic, and to validate the CTV data post-processing capabilities utilized in the
deoxygenation of RBCs. First, the RPMI media was evaluated to determine if it possessed
any magnetic properties. Then, cytosmears were created to image the cells. Next, the
magnetophoretic mobility was analyzed through CTV, and lastly, the ability to isolate
CSCs was explored with MDM.
To ensure the RPMI media did not present magnetic properties, and the magnetic
susceptibility was similar to that of water, the mean magnetic susceptibility values
measured with the MSB-Auto were compared through a t-Test assuming unequal variances
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for the means. The results from the t-Test between RPMI and MilliQ water are displayed
in Table VIII and the results from RPMI and distilled water are in Table IX.
Table VIII: Results of the t-Test between RPMI media and MilliQ water to determine how similar the magnetic
susceptibilities are between the two with five measurements for each.

t-Test: Two-Sample Assuming Unequal Variances
Statistical Parameter
χ of RPMI Media
χ of MilliQ Water
-6
Mean
-9.3110
-9.3210-6
t Stat
0.047
t Critical two-tail
2.57

Table IX: Results of the t-Test between RPMI media and distilled water to determine how similar the magnetic
susceptibilities are between the two with five measurements for each.

t-Test: Two-Sample Assuming Unequal Variances
Statistical Parameter
χ of RPMI Media
χ of Distilled Water
-6
Mean
-9.3110
-9.1010-6
t Stat
-0.73
t Critical two-tail
2.78

Upon reviewing the results of the statistical analysis, the t-stat value between RPMI and
MilliQ water is 0.047, which is between the positive and negative values of the t-critical
two-tail values, -2.571 and 2.571. Also, the t-stat value for RPMI and distilled water,
-0.726, is between -2.776 and 2.776, t-critical two-tail values. This information indicates
that the RPMI media does not have magnetic properties.
Due to time constraints of this project, none of the PFA fixed slides generated
through cytospin and MDM were fluorescently stained to be imaged. However, four
cytosmears created utilizing HEMA fixative were imaged, which are displayed in Figures
84-87. All the images were taken utilizing the same microscope within the ImageCore at
the Cleveland Clinic LRI, at the same magnification of 40 with a 15 µm scale bar in the
bottom right corner.
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Figure 84: Image of GL261 fixed with HEMA solution, imaged at 40 magnification on November 19, 2018.

Figure 85: Image of GL261 fixed with HEMA solution, imaged at 40 magnification on November 30, 2018.
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Figure 86: Image of GL261 fixed with HEMA solution, imaged at 40 magnification on December 5, 2018.

Figure 87: Image of GL261 fixed with HEMA solution, imaged at 40 magnification on December 14, 2018.
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As mentioned in Section 3.5.2, the procedure for analyzing the CTV results for the glioma
experiments followed the same procedure as the analysis for the deoxygenation
experiments. A total of 12 glioma experiments were completed for the GL261 and 3T3
cultures, and were analyzed with the MATLAB program found in Appendix B. These 12
experiments were analyzed utilizing the k-mean clustering concept described in Section
3.4.6 to differentiate bands of cells within a sample. Each experiment was run through the
MATLAB code two or three times with modifying the code to have the data be split into
two clusters and three clusters. Results from experiments completed on December 5th and
20th, 2018 for GL261 are presented below in Figures 88 – 91. As seen in Figures 89 and
91, the MATLAB code can differentiate between two subsets of cells within a sample. The
remainder of the results are in Appendix C.

Figure 88: Left: Scatter plot of original data obtained December 5, 2018. Right: Scatter plot of original data split into two
clusters.
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Figure 89: Gaussian plot of the two clusters presented in Figure 88.

Figure 90: Left: Scatter plot of original data obtained December 20, 2018. Right: Scatter plot of original data split into two
clusters.

127

Figure 91: Gaussian plot of the two clusters presented in Figure 90.

4.5 Results for Temperature Gradient Exploration
The main purpose of these calculations was to determine if applying a temperature
gradient to the MDM assembly would enhance RBC magnetic separation. Figure 92 depicts
the velocity profile, which was calculated from Equation 2.35, and varying the width by
0.01 mm increments until 0.25 mm, which is the width of the MDM channel. The slowest
velocity reached about -40.5 µm/s at 0.05 mm from the cold wall and the fastest velocity
was about 40.5 µm/s at a distance of 0.2 mm from the cold wall.
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Figure 92: Giddings velocity profile calculated within Excel.

The COMSOL simulations of the velocity profile were completed next. Figure 93
displays the results from attempt number one described in Section 3.6. The fastest velocity
was obtained at the outlet, which is the location of the syringe pump, at about 410-5 m/s.
The highest pressure was located at the inlet at about 2.5510-6 Pa.
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Figure 93: Above: Velocity profile through the manifold generated with COMSOL. Below: Pressure contours through the
manifold with COMSOL.
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4.6 Discussion for Sm Verification
Over 30 experiments were completed to verify the Sm value, utilizing different
concentrations of Magnevist and varying the position over a wider range and imaging at
smaller increments. The results presented in Section 4.1 in Figure 38, utilizing the 2.7 µm
PS particles and a 50/50 mixture of MDM buffer and Magnevist solution, verified the
location within the FOV with the highest Sm value and the least variability within the FOV
was positioned about 4.5 mm from the edge of the magnet. This confirmed the position in
Figure 11. However, when comparing the Sm values experimentally acquired to the model
value, the experimental value is almost 1.4 times higher. This did not confirm which value
for Sm should be utilized when completing CTV.
There are a few discrepancies which could cause the Sm value to be as high as the
results presented in Figure 38. The major issue could have been with the particle size.
Equation 2.15 demonstrates that the Sm value and the particle diameter are inversely
proportional, increasing Sm if the particle diameter is small. Therefore, if there were
aggregates within the sample solution, causing the particle size to be larger than what was
reported, then the Sm value would drop significantly. For example, if the diameter was
actually 4.010-3 mm, then the Sm value would be about 400 T-A/mm2. Another difference
could be the Video Savant and ImageView software are not tracking particles, but groups
of particles. This could be caused by too high of a particle concentration within the sample
and would cause the magnetophoretic mobility of the particles appear to be greater than
they actually are.
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4.7 Discussion for the Spectrophotometer Experiments
The spectrum results for wavelengths of 500 – 700 nm in Figure 39 closely
resemble the theoretical curves of oxyHb and metHb in Figure 17. Also, the characteristics
described by Winterbourn within her paper at wavelengths 560, 577, and 630 nm were
closely reflected (Winterbourn, 1990). Upon analysis utilizing Equations 2.32 – 2.34, the
concentration of oxyHb within the metHb sample was determined to be negligible, along
with the concentration of metHb found within the oxyHb sample. The concentrations which
were calculated agree with the spectrum presented in Figure 39 of the results.
4.8 Discussion for the Deoxygenation of Red Blood Cells
The results obtained through the MATLAB code and the Hill curve fitting analysis
both suggest that for Experiments 1 and 2, RBCs behave similarly to the theoretical models
from a pO2 at 0.1 mmHg to 160 mmHg. Also, for the points below 30 mmHg, the
magnetophoresis data indicated significant admixtures of partially oxygenated RBCs.
These results are in agreement with the Hill model, which demonstrates fully oxygenated
RBCs dominate within the mixture from 160 mmHg until 30-40 mmHg, where partially
oxygenated RBCs become noticeable. This is displayed in Figure 94 below.
This work has demonstrated that the current CTV equipment, modified for the
purpose of the deoxygenation of RBCs, is capable of determining both parameters, n and
k, that underlie the two-parameter Hill model. The values of those parameters, determined
by RBC magnetophoresis, are comparable to the literature values for normal blood
determined spectrophotometrically (Dash, et al., 2016). As stated by Dash, when the Hill
parameter n is set to 2.7, between oxygen saturation levels of 30% to 98%, Equation 2.27
is utilized. Any saturation levels above or below this range, the equation is inaccurately
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applied (Dash, et al., 2016). However, the current CTV equipment and the RBC
deoxygenation protocols did not provide the highest precision needed for the determination
of Adair parameters described in Section 2.7. It is technically plausible that such precision
could be achieved in the future with the further refinement of the CTV high magnetic field
assembly and more precise control over the RBC deoxygenation process.

Figure 94: Model of Adair’s equation generated in Maple by Dr. Zborowski. Indicates singly-, doubly-, triply-, fully
oxygenated, and fully deoxygenated RBC behavior at different partial pressures of O2. Graph of the fractional
concentrations of five hemoglobin-O2 complexes (left axis), and the corresponding hemoglobin-O2 equilibrium curve
(right axis) as a function of pO2 calculated from the Adair equation. Symbols nB describe the number of heme groups that
contribute to the paramagnetic dipole moment of the hemoglobin-O2 complex.

Analysis of the Hill curve slope values provide a measure of the cooperative
binding of O2 to the Fe2+ ferrous ion, Figure 2. Values of n>1 indicates when one O2
molecule is bond to the hemoglobin it is easier for the next O2 molecule to bind, positively
cooperative binding. When n<1, negative cooperative binding occurs, meaning if one O2
molecule is bond, then then next molecule will have a more difficult time to bind. Lastly,
for n=1 noncooperative (completely independent) binding exists, therefore, binding is
independent of the pO2 (Weiss, 1997). From these definitions of n, it was determined that
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for both Experiments 1 and 2, there is a slight indication of positive cooperative binding of
O2 to hemoglobin based on the n values for the fitted gaussian distributions. Based on the
p-values of the slope and intercepts for the regression lines and the R2 values being below
0.8, the experimental data is said to be significantly different from the regression line.
4.9 Discussion for the Glioma Experiments
The results for the original scatter plot for the experiment completed on December
5, 2018, there are two clusters seen in the histograms for the magnetic velocity and the
sedimentation velocity. When the data was analyzed with the MATLAB code, Figure 89
displays the two clusters of cells seen in the magnetic velocity histogram in Figure 88. The
results for the experiment completed on December 20, 2018 has a similar trend with the
magnetic and sedimentation velocity histograms showing signs of two clusters of cells in
each, Figure 91. Figures 89 and 91 demonstrate that there is a cluster of cells within the
sample which are more magnetic than the others in the sample. When looking at the right
plots in Figures 88 and 90, the clusters which are more magnetic, also sediment out of the
solution at a slower rate than the less magnetic clusters. Upon reviewing the results of the
statistical analysis, the t-stat value between RPMI and MilliQ water is 0.047, which is
between the positive and negative values of the t-critical two-tail values, -2.571 and 2.571.
Also, the t-stat value for RPMI and distilled water, -0.726, is between -2.776 and 2.776, tcritical two-tail values. This information indicates that the RPMI media does not have
magnetic properties. The cytosmears generated provide a reference to compare to the
MDM slides to determine if the MDM can isolate CSCs from cancer cells.
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4.10 Discussion for the Temperature Gradient Exploration
As seen in Section 4.5 in Figure 92, the maximum value obtained for the velocity
profile created in Excel was large enough to affect the RBC sedimentation by entrainment
in the falling or rising layer of water in the channel. However, due to limited knowledge of
how the COMSOL Multiphysics program works, and the limited time allotted to complete
the modeling, the attempts completed to obtain the velocity profile within the channel were
not successful. The results presented in Figure 93 of the velocity profile and the pressure
contours were in the manifold, not the channel. The remainder of the attempts did not
provide any results.
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CHAPTER V
CONCLUSION AND RECOMMENDATIONS
5.1 Conclusions and Recommendations: Sm Verification Experiments
The location from the edge of the magnet which produces the highest magnetic
energy density gradient (Sm) with the least variation in the magnitude over the FOV for the
Mk V magnet assembly was confirmed to be 4.5 mm. However, the value for Sm is still in
question due to the 140% difference from the values obtained through experiments
compared to the theoretical value generated through software. Therefore, the original value
of 365 T-A/mm2 will be utilized until further research is completed.
In the future, more experiments should be done at the confirmed 4.5 mm distance
from the edge of the magnet. When completing these studies, it is recommended to change
the mixture of Magnevist and MDM buffer from 50/50, to 25/75 while keeping the PS
particles the same. When a lower concentration of Magnevist is utilized, for example
0.5/99.5 mixture ratio of Magnevist to MDM buffer, the smaller particle would have a
lower velocity due to the viscous drag force being proportional to velocity of the particle.
This allows for the Video Savant imaging software to capture the motion of the PS
particles, without them moving too fast to be tracked. Lastly, decreasing the frame delay
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would permit for the fast-moving PS particles to be tracked in more images as well as
capturing the slower-moving particles before they sediment to the bottom of the channel.
5.2 Conclusions and Recommendations: Spectrophotometry
From the results obtained from the spectrophotometry experiments, it was
concluded that metHb sample was fully converted to metHb, while the oxyHb sample was
saturated with O2. This demonstrates that spectrophotometry is a reliable reference model
for RBC magnetophoresis. Recommendations for the future are to complete in process
testing for the RBC deoxygenation experiments in the spectrophotometer to verify
Winterbourn’s spectra for oxyHb and deoxyHb (surrogate metHb).
5.3 Conclusions and Recommendations: Red Blood Cell Deoxygenation Experiments
The RBC magnetophoretic analysis indicates the fully oxygenated RBCs dominant
in the sample until the pO2 reaches about 30-40 mmHg. As indicated by the graphs
generated from Adair’s equation by Dr. Zborowski in Maple, below this point is when the
partially oxygenated RBC, containing a significant fraction of high-spin hemoglobin, come
into consideration. These results agree with what is known about cooperative binding
between the pO2 values of 0 – 30 mmHg, that the fully oxygenated RBCs dominate until
this range is reached. Therefore, in order to study the RBC sample for its composition in
partially oxygenated hemoglobin, such a study needs to be focused on the low range of 030 mmHg. These results provided important insights into the opportunities and limitations
of the new technique of magnetophoretic RBC analysis. This information also confirms the
hypothesis that the magnetic susceptibility of RBCs does follow the same cooperative
binding dependence on pO2 as determined spectrophotometrically.
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The experiments of the deoxygenation of RBCs provided a basis for future studies.
It is recommended that more research be done for pO2 from 30-0 mmHg to determine if
singly-, doubly-, triply-, and fully oxygenated and deoxygenated RBCs are able to be
identified in this region in accordance with the Adair model. When completing future
experiments, instead of varying the pO2 from 160 mmHg to 0 mmHg as was done for the
experiments presented in this paper, start with 0 mmHg and go up in oxygenation until 160
mmHg. Testing blood that was stored for 42 days (from Dr. Mark Yazer at the University
of Pittsburgh, collaborator on the project) for differences in the RBC magnetically induced
velocity dependence on pO2 as compared to a freshly drawn blood sample is also a future
research consideration. Another recommendation for the future, is to use a small amount
of sample at each pO2 level and test it within the spectrophotometer to confirm
Winterbourn’s spectra for oxyHb and deoxyHb (surrogate metHb).
5.4 Conclusions and Recommendations: Glioma Experiments
The results from the t-test determined that the mean magnetic susceptibility value
for RPMI media was not statistically significantly different from the mean values of MilliQ
water and distilled water. Therefore, it was concluded that the RPMI media does not
present any magnetic properties which could be passed to the glioma cell causing them to
be magnetic.
The conclusion drawn from the results presented in Section 4.4 about the CTV
experiments, is that there may be two cell types within the GL261 culture samples provided
from Soumya in Dr. Lathia’s laboratory, but at this point in time the properties of the cells
are unknown. To understand these results more, the cytosmears and MDM slides need to
be fluorescently stained and imaged to determine if CSCs are more magnetic than the other
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cells present within the sample, and if they are able to be isolated through MDM. Also, it
is recommended to reanalyze the data through the MATLAB code to confirm the results
obtained in the experiments presented here. However, the sensitivity of the CTV postprocessing capabilities was validated based on the separation shown in the original scatter
plots in Figures 88 and 90.
5.5 Conclusions and Recommendations: Temperature Gradient Exploration
The Giddings velocity profile generated in Excel confirmed that introducing a
temperature gradient to the MDM channel would enhance the magnetic separation of
RBCs. Therefore, COMSOL modeling progressed to determine a more realistic
representation of the temperature gradient affects. Due to these results and discussion for
the COMSOL modeling, no information was provided for the velocity profile within the
channel. Also, the magnetic properties and the temperature gradient were not introduced
to the simulation. Therefore, no information was gained by completing these trials within
COMSOL. In the future it is recommended that someone with experience and knowledge
of COMSOL Multiphysics completes further exploration of the effects of a temperature
gradient applied to the MDM system.

139

REFERENCES
Bel-Art riteflow aluminum mounted flowmeter; 150mm scale, size 4. (1998). Retrieved
March 2019, from Bel-Art H-B Instrument: SP Scienceware:
www.belart.com/bel-art-h40407-0215-riteflow-aluminum-mounted-flowmeter150mm-scale-size-4.html.
Borradaile, G. J. (1998). Magnetic susceptibility, petrofabrics and strain. Tectonophysics,
156, 1-20. doi:10.1016/0040-1951(88)90279-X
Bostick, M. (2018). What goes on inside a spectrophotometer? Retrieved 2019, from
Carolina: https://www.carolina.com/teacher-resources/Interactive/what-goes-oninside-a-spectrophotometer/tr41103.tr
Brem, F., Hirt, A. M., Winklhofer, M., Frei, K., Yonekawa, Y., Wieser, H.-G., &
Dobson, J. (2006). Magnetic iron compounds in the human brain: a comparison of
tumour and hippocampal tissue. Journal of the Royal Society Interface, 3, 833841. doi:10.1098/rsif.2006.0133
Buck, A., Moore, L. R., Lane, C. D., Kumar, A., Stroff, C., White, N., . . . Zborowski, M.
(2014). Magnetic separation of algae genetically modified for increased
intracellular iron uptake. Journal of Magnetism and Magnetic Materials, 380,
201-204. doi:10.1016/j.jmmm.2014.09.008
Campbell, P. (1999). Permanent magnet materials and their application. Cambridge
University Press.
Cullity, B. D., & Graham, C. D. (2008). Introduction to magnetic materials (2 ed.). John
Wiley & Sons, Inc. Retrieved May 2019, from
www.gbv.de/dms/ilmenau/toc/497966662.PDF

140

Cytospin: Cell Preparation System Operator Guide. (1997). Retrieved 2019, from
Thermo Fisher Scientific: http://www.blockscientific.com/manuals/shandoncytospin-3-operator-guide.pdf
D'Alessandro, A., Dzieciatkowska, M., Nemkov, T., & Hansen, K. C. (2017). Red blood
cell proteomics update: is there more to discover? Blood Transfusion, 15, 182187. doi:10.2450/2017.0293-16
Dash, R. K., Korman, B., & Bassingthwaighte, J. B. (2016). Simple accurate
mathematical models of blood HbO2 and HbCO2 dissociation curves at varied
physiological conditions: evaluation and comparison with other models.
European Journal of Applied Physiology, 116, 97-113. doi:10.1007/s00421-0153228-3
Duan, J.-j., Qiu, W., Xu, S.-l., Wang, B., Ye, X.-z., Ping, Y.-f., . . . Yu, S.-c. (2013).
Strategies for isolating and enriching cancer stem cells: Well begun is half done.
Stem Cells and Development, 22, 2221-2239. doi:10.1089/scd.2012.0613
Erythrocytes. (2013). In Anatomy and Physiology. WordPress. Retrieved May 6, 2019,
from OpenTextbook: opentextbc.ca/anatomyandphysiology/chapter/18-3erythrocytes/
Fang, B., Zborowski, M., & Moore, L. R. (1999). Detection of rare MCF-7 breast
carcinoma cells from mixtures of human peripheral leukocytes by magnetic
deposition analysis. Cytometry, 36, 294-302.
Four different kinds of magnetism. (2016). Retrieved May 2019, from
web.hep.uiuc.edu/home/serrede/P435/Lecture_Notes/Magnetism.pdf.

141

Garbade, M. J. (2018). Understanding k-means clustering in machine learning. Retrieved
May 2019, from Towards Data Science: towardsdatascience.com/understandingk-means-clustering-in-machine-learning-6a6e67336aa1
GBM agile: A revolutionary new adaptive trial platform. (2019). Retrieved 2019, from
National Foudation for Cancer Research: https://www.nfcr.org/gbmagile/?gclid=EAIaIQobChMImoy_2ru64wIVi5OzCh0dTQJLEAAYAiAAEgIwlP
D_BwE#diseasem
Giangreco, G. J., Campbell, D., & Cowan, M. J. (2013). A 32-year-old female with AIDS,
Pneumocytis jiroveci pneumonia, and methemglobinemia. Hindawi Publishing
Corporation. doi:10.1155/2013/980589
Giddings, J. C. (1991). Unified Separation Science. John Wiley & Sons, Inc. Retrieved
2019
Haidas, S., Labie, D., & Kaplan, J.-C. (1971). 2,3-Diphosphoglycerate content and
oxygen affinity as a function of red cell age in normal individuals. Blood, 38, 463467. Retrieved May 2019, from http://www.bloodjournal.org/content/38/4/463
Hemoglobin: portrait of a protein in action . (2012). In Biochemistry (7 ed.). W. H.
Freeman and Company. Retrieved May 2019, from
http://ocw.sogang.ac.kr/rfile/2013/course07CHM1/biochemistry7e_ch07_20130620145200.pdf
Hill equation - interactive graph. (2014). Retrieved May 2019, from PhysiologyWeb:
https://www.physiologyweb.com/calculators/hill_equation_interactive_graph.htm
l

142

Hill, A. V. (1910). The possible effects of the aggregation of the molecules of
haemoglobin on its dissociation curves. The Journal of Physiology, 40, 4-7.
Retrieved April 2019, from mathgeomsrv2.epfl.ch/teaching/oldCourses/20172018/MathematicalPhysiology/protected_files/articles/Hill.pdf
Imai, K. (1994). Adair fitting to oxygen equilibrium curves of hemoglobin. Methods in
Emzymology, 232, 559-576. Retrieved 2019
Inglut, C., Kausch, K., Gray, A., & Landrigan, M. (2016). Rejuvenation of stored red
blood cells increases oxygen release capacity. Blood, 128. Retrieved April 2019,
from www.bloodjournal.org/content/128/22/4808
Jin, X., Chalmers, J. J., & Zborowski, M. (2012). Iron transport in cancer cell culture
suspensions measured by cell magnetophoresis. Analytical Chemistry, 84, 45024526. doi:10.1021/ac3004677
Joshi, P., Jacobs, B., Derakhshan, A., Moore, L. R., Elson, P., Triozzi, P. L., . . .
Zborowski, M. (2014). Enrichment of circulating melanoma cells (CMCs) using
negative selection from patients with metastatic melanoma. Oncotarget, 5, 24502461. Retrieved 2019
Joshi, P., Williams, P. S., Moore, L. R., Caralla, T., Boehm, C., Muschler, G., &
Zborowski, M. (2015). Circular halbach array for fast magnetic separation of
hyaluronan-expressing tissue progenitors. Analytical Chemistry, 87.
doi:10.1021/acs.analchem.5b02431
Kawabata, H., Yang, R., Hirama, T., Vuong, P. T., Kawano, S., Gombart, A. F., &
Koeffler, H. P. (1999). Molecular cloning of transferrin receptor 2 - a new

143

member of the transferrin receptor-like family. Journal of Biological Chemistry,
274, 20826-20832.
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L., & Rich, J. N.
(2015). Cancer stem cells in glioblastoma. Genes & Development, 29, 1203-1217.
doi:10.1101/gad.261982.115
Legato 210/210P Syringe Pump. (2016). Retrieved 2019, from kd Scientific: Syringe
Pumps & Dispensers: https://www.kdscientific.com/legato-210-210p-syringepump.html
Lide, D. R. (2005). CRC Handbook of Chemistry and Physics (85 ed.). CRC Press.
Retrieved April 2019, from
http://diyhpl.us/~nmz787/mems/unorganized/CRC%20Handbook%20of%20Che
mistry%20and%20Physics%2085th%20edition.pdf
Mader, S. (1997). Inquiry into life (8 ed.). The McGraw-Hill Inc. Retrieved April 2019
Magnetic susceptibility balances (MSB). (2005). Retrieved May 2019, from Johnson
Matthey: https://faculty.uca.edu/patrickd/chem3150/MSB1_Brochure.pdf
Magnetic susceptibility balances. (1930). Retrieved May 2019, from Sherwood
Scientific: http://www.sherwoodscientific.com/Magnetic%20Susceptibility%20Balance%20Brochure.pdf
Magnevist®. (2017). Retrieved May 2019, from Bayer Pharmaceuticals:
https://www.radiologysolutions.bayer.com/static/media/PDFs/2-2-13_Magnevist/Magnevist%20NDC%20Code%20One-sheet%20%20Electronic%20Version.pdf

144

Matejak, M., Kulhanek, T., & Matousek, S. (2015). Adair-based hemoglobin equilibrium
with oxygen, carbon dioxide and hydrogen ion activity.
doi:10.3109/00365513.2014.984320
Moore, L. R., Mizutani, D., Tanaka, T., Buck, A., Yazer, M., Zborowski, M., &
Chalmers, J. (2018). Continuous, intrinsic magnetic depletion of erythrocytes
from whole blood with a quadrupole magnet and annular flow channel; pilot scale
study. Biotechnology and Bioengineering, 115, 1521-1530. doi:10.1002/bit.26581
Moore, L. R., Zborowski, M., Nakamura, M., McCloskey, K., Gura, S., Zuberi, M., . . .
Chalmers, J. (2000). The use of magnetite-doped polymeric microspheres in
calibrating cell tracking velocimetry. Journal of Biochem Biophys Methods.
Retrieved 2019
Moore, L. R., Zborowski, M., Sun, L., & Chalmers, J. J. (1998). Lymphocyte
fractionation using immunomagnetic colloid and a dipole magnet flow cell sorter.
Journal of Biochemical Biophysical Methods, 37, 11-33.
Nakamura, M., Zborowski, M., Lasky, L. C., Margel, S., & Chalmers, J. (2001).
Theoretical and experimental analysis of the accuracy and reproducibility of cell
tracking velocimetry. Experiments in Fluids, 30, 371-380.
doi:10.1007/s003480000211
Oakton™ Gilmont™ shielded laboratory direct-reading flowmeters. (2006). Retrieved
May 2019, from Fisher Scientific: https://www.fishersci.com/shop/products/coleparmer-gilmont-shielded-laboratory-direct-reading-flowmeters-4/p-179228
Oh, T., Fakurnejad, S., Sayegh, E. T., Clark, A. J., Ivan, M. E., Z., S. M., . . . Parsa, A. T.
(2014). Immunocompetent murine models for the study of glioblastoma

145

immunotherapy. Journal of Translational Medicine, 12, 1-10. doi:10.1186/14795876-12-107
Orion star™ A213 dissolved oxygen benchtop meter. (2015). Retrieved May 2019, from
Thermo Fisher Scientific:
https://www.thermofisher.com/order/catalog/product/STARA2130
Orion™ RDO™ dissolved oxygen probe. (2008). Retrieved May 2019, from Thermo
Fisher Scientific:
https://www.thermofisher.com/order/catalog/product/087010MD?SID=srch-srp087010MD
Pauling, L., & Coryell, C. (1936a). The magnetic properties and structure of the
hemochromogens and related substances. Proceedings of the National Academy of
Sciences of the United States of America, 22, 159-163. doi:10.1073/pnas.22.3.159
Pauling, L., & Coryell, C. D. (1936b). The magnetic properties and structure of
hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proceeding of the
National Academy of Sciences of the United States of America, 22, 210-216.
doi:10.1073/pnas.22.4.210
Permanent magnet guidelines. (1998). Retrieved May 2019, from
https://www.intemag.com/images/MMPAPMG-88.pdf
Schonberg, D. L., Miller, T. E., Wu, Q., Flavahan, W. A., Das, N. K., Hale, J. S., . . .
Rich, J. N. (2015, October). Preferential iron trafficking characterizes
glioblastoma stem-like cells. Cancer Cell, 28, 441-455.
doi:10.1016/j.ccell.2015.09.002

146

Sparrow, R. L. (2010). Red blood cell storage and transfusion-related
immunomodulation. Blood Transfusion, 8, 26-30. doi:10.2450/2010.005S
Staff, M. C. (2019, April). Brain tumor: Ependymoma. Retrieved 2019, from Mayo
Clinic: https://www.mayoclinic.org/diseases-conditions/ependymoma/cdc20350144
Staff, M. C. (2019, April). Glioma. Retrieved 2019, from Mayo Clinic:
https://www.mayoclinic.org/diseases-conditions/glioma/symptoms-causes/syc20350251
Staff, M. C. (2019, April). Glioma: Astrocytoma. Retrieved 2019, from Mayo Clinic:
https://www.mayoclinic.org/diseases-conditions/astrocytoma/cdc-20350132
Staff, M. C. (2019, April). Glioma: Glioblastoma. Retrieved 2019, from Mayo Clinic:
https://www.mayoclinic.org/diseases-conditions/glioblastoma/cdc-20350148
Staff, M. C. (2019, April). Glioma: Oligodendroglioma. Retrieved 2019, from Mayo
Clinic: https://www.mayoclinic.org/diseases-conditions/oligodendroglioma/cdc20350152
The use of magnetite-doped polymeric microspheres in calibrating cell tracking
velocimetry. (2000). Journal of Biochemical and Biophysical Methods, 44, 1151130. doi:10.1016/S0165-022X(00)00085-3
Understanding permanent magnets. (2015). Retrieved May 2019, from Arnold Magnetic
Technologies: spontaneousmaterials.com/Papers/CW2000.pdf
User's guide: DU series 700 UV/Vis scanning spectrophotometer. (2012, December).
Retrieved 2019, from Beckman Coulter:
https://physiology.case.edu/media/eq_manuals/eq_manual_beckman_du700_.pdf

147

Water - density, specific weight and thermal expansion coefficient. (2003). Retrieved
2019, from Engineering ToolBox: https://www.engineeringtoolbox.com/waterdensity-specific-weight-d_595.html
Water - dynamic and kinematic viscosity. (2004). Retrieved 2019, from Engineering
ToolBox: https://www.engineeringtoolbox.com/water-dynamic-kinematicviscosity-d_596.html
Weiss, J. (1997). The hill equation revisited: uses and misuses. FASEB Journal, 11, 835841. doi:10.1096/fasebj.11.11.9285481
What is the magnetic hysteresis loop. (2015). Retrieved May 2019, from Arnold
Magnetic Technologies: https://www.arnoldmagnetics.com/wpcontent/uploads/2017/10/FINAL_Tech-Library_Tech-Notes_Hysteresis-Loop.pdf
Why patients receive blood transfusions. (2019). Retrieved 2019, from American Red
Cross: https://www.redcrossblood.org/donate-blood/blood-donationprocess/what-happens-to-donated-blood/blood-transfusions/reasonstransfusions.html
Williams, P. S., Carpino, F., & Zborowski, M. (2010, August). Characterization of
magnetic nanoparticles using programmed quadrupole magnetic field-flow
fractionation. Philosophical Transactions of the Royal Society, 368, 4419-4437.
doi:10.1098/rsta.2010.0133
Winslow, R., Swenberg, M., Berger, R., Shrager, R., Luzzana, M., Samaja, M., & RossiBernardi, L. (1977). Oxygen equilibrium curve of normal human blood and its
evaluation by adair's equation. The Journal of Biological Chemistry, 252, 23312337. Retrieved May 2019, from https://www.ncbi.nlm.nih.gov/pubmed/849931

148

Winterbourn, C. C. (1990). Oxidative Reactions of Hemoglobin. Methods in Enzymology,
186, 265-272. Retrieved 2019
Xue, W. (2016). Measurements of cellular intrinsic magnetism with cell tracking
velocimetry and separation with magnetic deposition microscopy. Dissertation,
The Ohio State University, Graduate Program in Chemical and Biomolecular
Engineering, Columbus. Retrieved May 2019, from
https://etd.ohiolink.edu/!etd.send_file?accession=osu1461231847&disposition=in
line
Xue, W., Moore, L. R., Nakano, N., Chalmers, J. J., & Zborowski, M. (2019). Single cell
magnetometry by magnetophoresis vs. bulk cell suspension magnetometry by
squid-mpms- a comparison. Journal of Magnetism and Magnetic Materials, 474,
152-160. doi:10.1016/j.jmmm.2018.10.108
Zborowski, M., & Chalmers, J. J. (Eds.). (2007). Magnetic cell separation (1 ed., Vol.
32). Elsevier Science. Retrieved May 2019
Zborowski, M., Chalmers, J. J., & Lowrie, W. G. (2016). Magnetic cell manipulation and
sorting. Microtechnology for Cell manipulation and Sorting, 15-55.
doi:10.1007/978-3-319-44139-9_2
Zborowski, M., Chalmers, J., & Moore, L. R. (2003). United States of America Patent
No. 6557430. Retrieved May 2019, from
https://patents.justia.com/patent/6557430
Zborowski, M., Fuh, C. B., Green, R., Sun, L., & Chalmers, J. J. (1995). Analytical
magnetapheresis of ferritin-labeled lymphocytes. Analytical Chemistry, 67, 37023712. doi:10.1021/ac00116a014

149

Zborowski, M., Ostera, G. R., Moore, L. R., Milliron, S., Chalmers, J. J., & Schechter, A.
N. (2003). Red blood cell magnetophoresis. Biophysical Journal, 84, 2638-2645.
doi:10.1016/S0006-3495(03)75069-3
Zimmerman, P. A., Thomson, J. M., Fujioka, H., Collins, W. E., & Zborowski, M.
(2006). Diagnosis of malaria by magnetic deposition microscopy. American
Society of Tropical Medicine and Hygiene, 74, 568-572. Retrieved 2019

150

APPENDIX A: RELEVANT GRAPHS AND TABLES
Table X: Common forms of magnetic susceptibility designation, units, and conversion factors (Zborowski, et al., 2016).

Magnetic Susceptibility Common Forms and Conversion Factors
Susceptibility
Conversion factor from
Symbol
χ (CGS units) χ (SI units)
Designation
CGS to SI
Volume
χ
1
1
4π
3
3
Mass/Specific
χg
cm /g
m /kg
4π/1000
3
m /mol or
4π/106 or 4π/1000,
Molar
χN
cm3/mol
3
m /kmol
respectively
3
One-gramm /mol or
4π/106 or 4π/1000,
χ'N
cm3/mol
3
formula-weight
m /kmol
respectively
Table XI: Specifications for the Beckman Coulter spectrophotometer (User's guide: DU series 700 UV/Vis scanning
spectrophotometer, 2012)

Beckman Coulter DU® 730 Specifications
Parameter
Value
Operating Mode
Transmittance %, Absorbance, Concentration
Source Lamp
Tungsten (visible), Deuterium (UV)
Wavelength Range
190 - 1100
Wavelength Accuracy
± 1 in 200 - 900 range
Wavelength Resolution
Selectable - 0.1, 0.2, 0.5, 1.0, 2.0, 5.0
Wavelength Calibration
Automatic
Wavelength Selection
Automatic, based on mode selected
Spectral Bandwidth
3
Photometric Readout
-0.3 - 3.0 A, 0.1 - 100 %T
Photometric Accuracy
± 0.005 A at 0 A - 0.5 A, 1% at 0.5 A - 2.0 A
Photometric Linearity
<0.5% at 2.0 A, 1% at > 2.0 A

Unit

nm
nm
nm

nm

Table XII: Specifications for the Oakton™ Gildmont™ Shielded laboratory Direct-Reading Flowmeter (Oakton™
Gilmont™ shielded laboratory direct-reading flowmeters, 2006).

Oakton™ Gildmont™ Shielded laboratory Direct-Reading Flowmeter Specifications
Parameter
Range
Units
Flow Rate
0.002 - 1.1
mL/min
Accuracy
± 5 of reading
%
Repeatability
± 1 of reading
%
Maximum Temperature
65
°C
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Table XIII: Specifications for the Bel-Art™ SP Scienceware™ Riteflow™ Mounted Flowmeter (Bel-Art riteflow
aluminum mounted flowmeter; 150mm scale, size 4, 1998).

Bel-Art™ SP Scienceware™ Riteflow™ Mounted Flowmeter Specifications
Parameter
Range
Units
Flow Rate
1.1 - 20.4
mL/min
Accuracy
± 5 of full scale
%
Repeatability
± 0.25 of full scale
%
Maximum Temperature
121
°C
Maximum Pressure
200
psig
Table XIV: Specifications for the RDO® Rugged DO sensor operated in the deoxygenation vessel for the deoxygenation
of RBCs experiments (Orion™ RDO™ dissolved oxygen probe, 2008).

RDO® Rugged Dissolved Oxygen Sensor Specifications
Parameter
Range
Dissolved Oxygen Concentration
0 - 20
Dissolved Oxygen Saturation
0 - 200
±0.1 mg/L up to 8 mg/L
Dissolved Oxygen Concentration Accuracy
±0.2 mg/L up from 8 to 20 mg/L
Dissolved Oxygen Concentration Resolution
0.01
Temperature
0 - 50
Temperature Accuracy
±0.3
Minimum Immersion Depth
40

Units
mg/L
%
mg/L
mg/L
mg/L
°C
°C
mm

Table XV: Dimensions for the RDO® Rugged DO sensor used in the deoxygenation vessel for the deoxygenation of
RBCs experiments (Orion™ RDO™ dissolved oxygen probe, 2008).

RDO® Rugged Dissolved Oxygen Sensor Dimensions
Parameter
Value
Sensor Tip Length
70
Overall Sensor Length
190
Sensor Tip Diameter
16
Maximum Sensor Diameter
33
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Units
mm
mm
mm
mm

Table XVI: Specifications for the Orion Star A213 DO Benchtop meter utilized for the deoxygenation of RBCs
experiments (Orion star™ A213 dissolved oxygen benchtop meter, 2015).

Orion Star A213 DO Benchtop Meter Specifications
Parameter
Range
Concentration
0 - 50
Concentration Resolution
0.01/0.1
±0.1 mg/L up to 8 mg/L
Concentration Relative Accuracy
±0.2 mg/L up from 8 to 20 mg/L
Saturation
0 - 500
Saturation Resolution
0.1/1
Saturation Relative Accuracy
±2 % saturation ≤ 200 %
Temperature
0 - 50
Temperature Resolution
0.1
Temperature Relative Accuracy
±0.1

Units
mg/L
mg/L
mg/L
mg/L
%
%
%
°C
°C
°C

Table XVII: Specifications and dimensions of the Shandon Cytospin 3 (Cytospin: Cell Preparation System Operator
Guide, 1997).

Shandon Cytospin 3 Specifications
Parameter
Value
Operating Speed Range
200 - 2,000
Height
215
Height Clearance
560
Width
385
Width Clearance
405
Depth
495
Depth Clearance
556
Weight
18

Units
rpm
mm
mm
mm
mm
mm
mm
kg

Table XVIII: Specifications of the Legato 210P multi-syringe pump (Legato 210/210P Syringe Pump, 2016).

Legato® 210/210P Syringe Pump Specifications
Parameter
Value
Accuracy
± 0.35
Minimum Syringe Size
0.5
Maximum Syringe Size
140
Minimum Flow Rate for 0.5 µL Syringe
3.06
Maximum Flow Rate for 140 mL Syringe
215.8
Minimum Step Rate
27.5
Maximum Step Rate
26
Minimum Pusher Travel Rate
0.36
Maximum Pusher Travel Rate
190.8
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Units
%
µL
mL
pL/min
mL/min
sec/µstep
µsec/µstep
µm/min
mm/min

APPENDIX B: MATLAB CODE FOR ANALYZING CTV RESULTS – 4/17/2019
Authors: Robert Royer, Dr. Maciej Zborowski, and Nina Smith
Select CTV macro file
Program will pull data from the 'DATA-1' sheet to build plots
clear
[file,path] = uigetfile('*.xlsx');
cd(path);
x = xlsread(file,'DATA-1','B:B');
y = xlsread(file,'DATA-1','C:C');
x = -x;
%% Magnet is flipped over
y = -y;
%% Makes sedimentaion rate below zero
x1 = x;
% stores gated data
y1 = y;
% stores gated data
x2 = x1;
% stores original data
y2 = y1;
% stores original data
lx=length(x)
ly=length(y)
lx1=lx;
ly1=ly;
minX=min(x)
maxX=max(x)
minY=min(y)
maxY=max(y)
%xlimLo=min(minX,minY);
%xlimHi=max(maxX,maxY);
%ylimLo=xlimLo;
%ylimHi=xlimHi;
xlimLo=-0.002
xlimHi=0.005
ylimLo=xlimLo
ylimHi=xlimHi
minX1=min(x)
maxX1=max(x)
minY1=min(y)
maxY1=max(y)

Scatter plot with marginal histograms
Position is defined by [x y xlength ylength]
position is determined by the bottom-left corner
binN=10
% average number of histogram counts per bin
Nbins = floor(lx1/binN)
% number of histogram bins is 1/binN of sample
size
binX=((maxX1-minX1)/Nbins)
% bin length
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figure1 = figure('Name',sprintf('file name is
%s',file),'NumberTitle','off');
axes1 = axes('Parent',figure1,'Position',[0.3 0.08 0.35 0.35],'Box','on');
hold(axes1,'on');
%axis 'equal'

% scatplot(x1,y1,'method',radius, N, number of filter coeffs., plot option
number, marker size)
% N square grid size, determines number of isolines
% 'method' = "circles", "squares", or "voronoi" (default)
% po number = 0 (no plot), 1 (scatter filtered), 2 (scatter & isolines
filter), 3 (as in 1 unfiltered), and 4 (as in 2 unfiltered)
% Example:
%scatplot(x1,y1,'circles',0.01,100,7,2,10)

scatplot(x1,y1)
pbaspect([1 1 1]);
xlabel('Magnetic Velocity, mm/s')
ylabel('Sedimentation Velocity, mm/s')
%xlim([minX1 maxX1])
%ylim([minY1 maxY1])
xlim([xlimLo xlimHi])
ylim([ylimLo ylimHi])
axis([xlimLo xlimHi ylimLo ylimHi])

colorbar('peer',axes1,'Position',[0.77 0.08 0.01 0.35])

axes2 = axes('Parent',figure1,'Position',[0.34 0.52 0.26 0.2],'Box','on');
hold(axes2,'on');
histogram(x1,Nbins,'DisplayStyle','stairs')
ylabel('Count')
title(file)
%Changes depending on which file is being run

axes3 = axes('Parent',figure1,'Position',[0.63 0.08 0.133
0.35],'Box','on');
hold(axes3,'on');
histogram(y1,Nbins,'Orientation','horizontal','DisplayStyle','stairs')
pbaspect([1 3 1])
xlabel('Count')

linkaxes([axes1,axes2],'x')
linkaxes([axes1,axes3],'y')
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histoP=histogram(x1,Nbins,'DisplayStyle','stairs');
hold off
clf

Histogram for full Set x1 using "histcounts" and "stairs" plot
clear N edgesN histoN
[Nx1,edgesN] = histcounts(x1,Nbins);
length(edgesN);
length(Nx1);
clf
histoN=stairs(edgesN(1:length(edgesN)-1),Nx1);
have to be same length for plotting
%hold on

% vector "edges" and "N"

K mean clustering analysis. Caution - assigns clusters differently each time it is run. Re-run
to make sure that the plot displays properly.
K is the number of clusters in the data
K
KMI

= 2
= 10

% Cluster Number
% K-means Iteration

Concatenate x and y vectors horizontally to form F(N,2) array for cluster analysis
x0=x1;
y0=y1;
F=horzcat(x0,y0);
clf

CENTS = F( ceil(rand(K,1)*size(F,1)) ,:);
DAL
= zeros(size(F,1),K+2);
Labels
CV
= '+r+b+c+m+yorobocomokoysrsbscsmsksy';

for n = 1:KMI
for i = 1:size(F,1)
for j = 1:K
DAL(i,j) = norm(F(i,:) - CENTS(j,:));
end
[Distance, CN] = min(DAL(i,1:K));
from Cluster Centers 1:K
DAL(i,K+1) = CN;
Label
DAL(i,K+2) = Distance;
Distance
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% Cluster Centers
% Distances and
% Color Vector

% n1:K are Distance
% K+1 is Cluster
% K+2 is Minimum

end
for i = 1:K
A = (DAL(:,K+1) == i);
CENTS(i,:) = mean(F(A,:));
Centers
NC = find(isnan(CENTS(:,1)) == 1);
for Ind = 1:size(NC,1)
CENTS(NC(Ind),:) = F(randi(size(F,1)),:);
end
end
end
CENTS

% Cluster K Points
% New Cluster
% Find Nan Centers

Plot
clf
figure(1)
hold on

for i = 1:K
PT = F(DAL(:,K+1) == i,:);
% Find points of
each cluster
plot(PT(:,1),PT(:,2),CV(2*i-1:2*i),'LineWidth',2);
% Plot points with
determined color and shape
plot(CENTS(:,1),CENTS(:,2),'*k','LineWidth',7);
% Plot cluster
centers
text(xlimHi/50+CENTS(i,1),xlimHi/50+CENTS(i,2),num2str(i),'FontSize',20)
end
xlabel('Magnetic Velocity, mm/s')
ylabel('Sedimentation Velocity, mm/s')
title(file)
hold off
grid on

**** Select index "i" for a Cluster selected as Subset B (exluded from Subset A)
iB=1;
PW = F(DAL(:,K+1) == iB,:);
F2=vertcat(PW);
x1b=F2(:,1);
y1b=F2(:,2);
lx1b=length(x1b)
ly1b=length(y1b)

% Find points for Cluster B

Select Cluster(s) for Subset A, then plot it for easy reference.
clf
%figure(1);
hold on
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%PU=zeros(lx1,2);
PU=[];
for i = 1:K
if i~=iB
PT = F(DAL(:,K+1) == i,:);
each cluster
plot(PT(:,1),PT(:,2),CV(2*i-1:2*i),'LineWidth',2);
with determined color and shape
plot(CENTS(:,1),CENTS(:,2),'*k','LineWidth',7);
centers

% Find points of
% Plot points
% Plot cluster

text(xlimHi/50+CENTS(i,1),xlimHi/50+CENTS(i,2),num2str(i),'FontSize',20);
PU=vertcat(PU,PT);
end
end

hold off
grid on

%scatter(PU(:,1),PU(:,2),'c');
hold on
%scatter(PW(:,1),PW(:,2),'b');
hold off

Combine data vectors of clusters included in Subset A
F1=PU;
x1a=F1(:,1);
y1a=F1(:,2);
lx1a=length(x1a)
ly1a=length(y1a)
min(x1a)
max(x1a)
Scatter plot with marginal histograms for Subset A
Position is defined by [x y xlength ylength]
position is determined by the bottom-left corner
lx1(1)
% full sample size (w/o outliers)
binA=lx1a
% Subset A size
Nbins(1)
% full sample histogram bin #
binXa=binX(1)
% Subset A histogram bin size = full histogram
bin size
Abins=abs(floor((max(x1a)-min(x1a))/binXa))
CENTS1(1,1)=mean(x1a);
% CENTS matrix expanded by addition of SD
columns
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CENTS1(1,2)=std(x1a);
columns
CENTS1(1,3)=mean(y1a);
columns
CENTS1(1,4)=std(y1a);
columns

% CENTS matrix expanded by addition of SD
% CENTS matrix expanded by addition of SD
% CENTS matrix expanded by addition of SD

clear figure1
%figure1 = figure('Name','Figure');
figure1 = figure('Name',sprintf('file name is
%s',file),'NumberTitle','off');
axes1 = axes('Parent',figure1,'Position',[0.3 0.08 0.35 0.35],'Box','on');
hold(axes1,'on')
%axis 'equal'

% scatplot(x1a,y1a,'method',radius, N, number of filter coeffs., plot
option number, marker size)
% N square grid size, determines number of isolines
% 'method' = "circles", "squares", or "voronoi" (default)
% po number = 0 (no plot), 1 (scatter filtered), 2 (scatter & isolines
filter), 3 (as in 1 unfiltered), and 4 (as in 2 unfiltered)
% Example:
%scatplot(x1,y1,'circles',0.01,100,7,2,10)

scatplot(x1a,y1a)
pbaspect([1 1 1])
title('Subset A')
xlabel('u_mag, mm/s')
ylabel('v, mm/s')
xlim([minX1 maxX1])
ylim([minY1 maxY1])
%xlim([xlimLo xlimHi])
%ylim([ylimLo ylimHi])

colorbar('peer',axes1,'Position',[0.77 0.08 0.01 0.35])

axes2 = axes('Parent',figure1,'Position',[0.34 0.52 0.26 0.2],'Box','on');
hold(axes2,'on');
histogram(x1a,Abins,'DisplayStyle','stairs')
ylabel('Count')

axes3 = axes('Parent',figure1,'Position',[0.63 0.08 0.133
0.35],'Box','on');
hold(axes3,'on');
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histogram(y1a,Abins,'Orientation','horizontal','DisplayStyle','stairs')
pbaspect([1 3 1])
xlabel('Count')

linkaxes([axes1,axes2],'x')
linkaxes([axes1,axes3],'y')
hold off

Scatter plot with marginal histograms for Subset B
Position is defined by [x y xlength ylength]
position is determined by the bottom-left corner
lx1(1)
% full sample size (w/o outliers)
binB=lx1b
% Subset A size
Nbins(1)
% full sample histogram bin #
binXb=binX(1)
Bbins=abs(floor((max(x1b)-min(x1b))/binXb))
CENTS1(2,1)=mean(x1b);
% CENTS matrix expanded by addition of SD
columns
CENTS1(2,2)=std(x1b);
% CENTS matrix expanded by addition of SD
columns
CENTS1(2,3)=mean(y1b);
% CENTS matrix expanded by addition of SD
columns
CENTS1(2,4)=std(y1b);
% CENTS matrix expanded by addition of SD
columns

clear figure1
%figure1 = figure('Name','Figure');
figure1 = figure('Name',sprintf('file name is
%s',file),'NumberTitle','off');

axes1 = axes('Parent',figure1,'Position',[0.3 0.08 0.35 0.35],'Box','on');
hold(axes1,'on')
%axis 'equal'

% scatplot(x1,y1,'method',radius, N, number of filter coeffs., plot option
number, marker size)
% N square grid size, determines number of isolines
% 'method' = "circles", "squares", or "voronoi" (default)
% po number = 0 (no plot), 1 (scatter filtered), 2 (scatter & isolines
filter), 3 (as in 1 unfiltered), and 4 (as in 2 unfiltered)
% Example:
%scatplot(x1,y1,'circles',0.01,100,7,2,10)
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scatplot(x1b,y1b)
pbaspect([1 1 1])
xlabel('u_mag, mm/s')
ylabel('v, mm/s')
title('Subset B')
xlim([minX1 maxX1])
ylim([minY1 maxY1])
%xlim([xlimLo xlimHi])
%ylim([ylimLo ylimHi])

colorbar('peer',axes1,'Position',[0.77 0.08 0.01 0.35])

axes2 = axes('Parent',figure1,'Position',[0.34 0.52 0.26 0.2],'Box','on');
hold(axes2,'on');
histogram(x1b,Bbins,'DisplayStyle','stairs')
ylabel('Count')

axes3 = axes('Parent',figure1,'Position',[0.63 0.08 0.133
0.35],'Box','on');
hold(axes3,'on');
histogram(y1b,Bbins,'Orientation','horizontal','DisplayStyle','stairs')
pbaspect([1 3 1])
xlabel('Count')

linkaxes([axes1,axes2],'x')
linkaxes([axes1,axes3],'y')
hold off

Histogram and Gaussian fit for Subset A using "histcounts" and "stairs" plot
clear N edges histoA
[NA,edgesA] = histcounts(x1a,Abins);
length(edgesA)
length(NA)
clf
histoA=stairs(edgesA(1:length(edgesA)-1),NA);
have to be same length for plotting
hold on

% vector "edges" and "N"

Gaussian fit for Subset A
xG=edgesA(1:length(edgesA)-1).';
% transpose rows to columns
yG=NA.';
% transpose rows to columns
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options = fitoptions('gauss1', 'Lower', [0 xlimLo 0], 'Upper', [1000
xlimHi xlimHi]);
ff=fit(xG,yG,'gauss1',options)
Plot data and fit for Subset A
%plot(ff);
xlim([xlimLo xlimHi])
legend('off')
hold off
Fit parameters for Subset A
clear a1 b1 c1
coeff=coeffvalues(ff)
a1=coeff(1)
b1=coeff(2)
c1=coeff(3)
Confidence Intervals for Gaussian peak position fitted to Subset A
ci = confint(ff,0.95);
CIloA=ci(1,2)
CIhiA=ci(2,2)

Histogram for Subset B using "histcounts" function and "stairs" plot
%clear N edges
[NB,edgesB] = histcounts(x1b,Bbins);
length(edgesB)
length(NB)
clf
histoB=stairs(edgesB(1:length(edgesB)-1),NB);
have to be same length for plotting
hold on

% vector "edges" and "N"

Gaussian fit for Subset B
xG=edgesB(1:length(edgesB)-1).';
% transpose rows to columns
yG=NB.';
% transpose rows to columns
options = fitoptions('gauss1', 'Lower', [0 xlimLo 0], 'Upper', [1000
xlimHi xlimHi]);
ff1=fit(xG,yG,'gauss1',options)
Plot data and fit for Subset B
%plot(ff1,'b')
xlim([xlimLo xlimHi])
legend('off')
hold off
Fit parameters for Subset B
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clear a2 b2 c2
coeff=coeffvalues(ff1)
a2=coeff(1)
b2=coeff(2)
c2=coeff(3)
Confidence Intervals for Gaussani fit peak position for Subset B
ci = confint(ff1,0.95);
CIloB=ci(1,2)
CIhiB=ci(2,2)

Plot Subset A and B Gaussians, their sum & original (Subset A+Subset B) histogram
%xf=minX1:binX:maxX1;
xf=xlimLo:binX:xlimHi;
sumff=feval(ff,xf)+feval(ff1,xf);
plot(ff,'r')
hold on
plot(ff1,'m')
plot(xf,sumff,'k')
histogram(x1,Nbins,'DisplayStyle','stairs')
xlim([xlimLo xlimHi])
legend('off')
title(file)
xlabel('Magnetic Velocity, mm/s')
ylabel('Count')
hold off

Welch's t test (unequal variances and sample sizes)
N1=binA
Amean=mean(x1a)
Asd=std(x1a)

% use mean x1a for t statistic
% use SD x1a for t statistic

N2=binB
Bmean=mean(x1b)
Bsd=std(x1b)

% use mean x1b for t statistic
% use SD x1b for t statistic

v = ((Asd^2/N1+Bsd^2/N2))^2/((Asd^4/N1^2/(N1-1)+Bsd^4/N2^2/(N2-1)))
tval = ((Amean)-(Bmean)) / sqrt((Asd^2/N1+Bsd^2/N2))

tdist2T = @(t,v) (1-betainc(v/(v+t^2),v/2,0.5));
distribution
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% 2-tailed t-

tdist1T = @(t,v) 1-(1-tdist2T(t,v))/2;
distribution
tprob = 1-[tdist2T(tval,v) tdist1T(tval,v)]

% 1-tailed t-

Welch's t test CIs of the mean
alpha=0.05
level p)
fun = @(t) tdist2T(t,v)-(1-alpha);
xrange = 1e-6;
procedure

% select parameter alpha (significance
% function of t alone
% initial point (or range) for fzero

Subset A CIs of the mean
alpha
v=N1-1
tval0 = fzero(fun,xrange)
Amean
LCLA=Amean-Asd/sqrt(N1)*abs(tval0)
UCLA=Amean+Asd/sqrt(N1)*abs(tval0)
Subset B CIs of the mean
v=N2-1
tval0 = fzero(fun,xrange)
Bmean
LCLB=Bmean-Bsd/sqrt(N2)*abs(tval0)
UCLB=Bmean+Bsd/sqrt(N2)*abs(tval0)
Compare with Gauss fit CI's
CIloA
CIhiA
CIloB
CIhiB
Write to Excel
filename = 'C:\Users\adamm\Documents\Thesis\Analysis Data.xlsx';

sheet='All'
xlswrite(filename,[x1 y1],sheet)

sheet='A'
xlswrite(filename,[x1a y1a],sheet)

sheet='B'
xlswrite(filename,[x1b y1b],sheet)

164

sheet='CENTS'
colHead = {'xM','SD','yM','SD'};
x1Range='B1'
rowHead = {'SubA';'SubB'};
y1Range='A2'
xlswrite(filename,colHead,sheet,x1Range)
xlswrite(filename,rowHead,sheet,y1Range)
xlswrite(filename,CENTS1,sheet,'B2')

sheet='GaussA'
Gcoeffs=coeffvalues(ff).'
colHead = {'Gauss coeffs'};
x1Range='B1'
rowHead = {'a';'b';'c'};
y1Range='A2'
xlswrite(filename,colHead,sheet,x1Range)
xlswrite(filename,rowHead,sheet,y1Range)
xlswrite(filename,Gcoeffs,sheet,'B2')

sheet='GaussB'
Gcoeffs=coeffvalues(ff1).'
colHead = {'Gauss coeffs'};
x1Range='B1'
rowHead = {'a';'b';'c'};
y1Range='A2'
xlswrite(filename,colHead,sheet,x1Range)
xlswrite(filename,rowHead,sheet,y1Range)
xlswrite(filename,Gcoeffs,sheet,'B2')

sheet='Ttest'
alphaN=alpha(1);
N1N=N1(1);
AmeanN=Amean(1);
AsdN=Asd(1);
N2N=N2(1);
BmeanN=Bmean(1);
BsdN=Bsd(1);
vN=v(1);
tvalN=tval(1);
tprobeN11=tprob(1,1);
tprobeN12=tprob(1,2);
Tcoeffs=[alpha;N1N;AmeanN;AsdN;N2N;BmeanN;BsdN;vN;tvalN;tprobeN11;tprobeN1
2]
colHead = {'Welch t test'};
x1Range='B1'
rowHead =
{'alpha';'N1';'Amean';'Asd';'N2';'Bmean';'Bsd';'v';'tval';'tail2';'tail1'}

165

y1Range='A2'
xlswrite(filename,colHead,sheet,x1Range)
xlswrite(filename,rowHead,sheet,y1Range)
xlswrite(filename,Tcoeffs,sheet,'B2')

sheet='CIs'
UCLAN=UCLA(1);
LCLAN=LCLA(1);
UCLBN=UCLB(1);
LCLBN=LCLB(1);
CIloAN=CIloA(1);
CIhiAN=CIhiA(1);
CIloBN=CIloB(1);
CIhiBN=CIhiB(1);
CITcoeffs=[UCLAN,LCLAN,UCLBN,LCLBN;CIhiAN,CIloAN,CIhiBN,CIloBN]
colHead = {'UCLA','LCLA','UCLB','LCLB'};
x1Range='B1'
rowHead = {'Ttest';'Gauss fit'}
y1Range='A2'
xlswrite(filename,colHead,sheet,x1Range)
xlswrite(filename,rowHead,sheet,y1Range)
xlswrite(filename,CITcoeffs,sheet,'B2')
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APPENDIX C: RESULTS GENERATED BY THE MATLAB CODE FOR THE
GLIOMA EXPERIMENTS

Figure 95: MATLAB results generated for 2 clusters the experiment completed by Matt Nagy for a GL261 on August 21,
2018.

167

Figure 96: MATLAB results generated for 2 clusters the experiment completed by Matt Nagy for a GL261 on August 28,
2018.
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Figure 97: MATLAB results generated for 3 clusters the experiment completed by Matt Nagy for a GL261 on August 28,
2018.
The red and navy clusters were combined as cluster 1 while the light blue cluster was cluster 2.
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Figure 98: MATLAB results generated for 2 clusters the experiment completed for a GL261 on October 15, 2018.

170

Figure 99: MATLAB results generated for 2 clusters the experiment completed for a GL261 on November 19, 2018.
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Figure 100: MATLAB results generated for 2 clusters the experiment completed for a GL261 on November 30, 2018.
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Figure 101: MATLAB results generated for 3 clusters the experiment completed for a GL261 on November 30, 2018.
The red and navy clusters were combined as cluster 1 while the light blue cluster was cluster 2.
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Figure 102: MATLAB results generated for 2 clusters the experiment completed for a GL261 on December 14, 2018.
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Figure 103: MATLAB results generated for 2 clusters the experiment completed for a GL261 on January 15, 2019.
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